| Year |
Citation |
Score |
| 2023 |
Parte S, Kaur AB, Nimmakayala RK, Ogunleye AO, Chirravuri R, Vengoji R, Leon F, Nallasamy P, Rauth S, Alsafwani ZW, Lele S, Cox JL, Bhat I, Singh S, Batra SK, et al. Cancer-associated Fibroblast Induces Acinar-to-ductal Cell Transdifferentiation and Pancreatic Cancer Initiation via LAMA5/ITGA4 axis. Gastroenterology. PMID 38154529 DOI: 10.1053/j.gastro.2023.12.018 |
0.391 |
|
| 2023 |
Lall SP, Alsafwani ZW, Batra SK, Seshacharyulu P. ASPORIN: A root of the matter in tumors and their host environment. Biochimica Et Biophysica Acta. Reviews On Cancer. 1879: 189029. PMID 38008263 DOI: 10.1016/j.bbcan.2023.189029 |
0.337 |
|
| 2023 |
Shah A, Chaudhary S, Lakshmanan I, Aithal A, Kisling SG, Sorrell C, Marimuthu S, Gautam SK, Rauth S, Kshirsagar P, Cox JL, Natarajan G, Bhatia R, Mallya K, Rachagani S, ... ... Batra SK, et al. Chimeric antibody targeting unique epitope on onco-mucin16 reduces tumor burden in pancreatic and lung malignancies. Npj Precision Oncology. 7: 74. PMID 37567918 DOI: 10.1038/s41698-023-00423-7 |
0.343 |
|
| 2023 |
Turner MA, Cox KE, Neel N, Amirfakhri S, Nishino H, Clary BM, Hosseini M, Natarajan G, Mallya K, Mohs AM, Hoffman RM, Batra SK, Bouvet M. Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Model: A Proof-of-Concept Study. Journal of Personalized Medicine. 13. PMID 37241027 DOI: 10.3390/jpm13050857 |
0.345 |
|
| 2023 |
Kumar N, Rachagani S, Natarajan G, Crook A, Gopal T, Rajamanickam V, Kaushal JB, Nagabhishek SN, Powers R, Batra SK, Saraswathi V. Histidine Enhances the Anticancer Effect of Gemcitabine against Pancreatic Cancer via Disruption of Amino Acid Homeostasis and Oxidant-Antioxidant Balance. Cancers. 15. PMID 37174059 DOI: 10.3390/cancers15092593 |
0.321 |
|
| 2023 |
Gautam SK, Khan P, Natarajan G, Atri P, Aithal A, Ganti AK, Batra SK, Nasser MW, Jain M. Mucins as Potential Biomarkers for Early Detection of Cancer. Cancers. 15. PMID 36980526 DOI: 10.3390/cancers15061640 |
0.328 |
|
| 2023 |
Cox KE, Liu S, Lwin TM, Hoffman RM, Batra SK, Bouvet M. The Mucin Family of Proteins: Candidates as Potential Biomarkers for Colon Cancer. Cancers. 15. PMID 36900282 DOI: 10.3390/cancers15051491 |
0.345 |
|
| 2022 |
Nallasamy P, Nimmakayala RK, Parte S, Are AC, Batra SK, Ponnusamy MP. Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis. Molecular Cancer. 21: 225. PMID 36550571 DOI: 10.1186/s12943-022-01682-x |
0.348 |
|
| 2022 |
Lakshmanan I, Marimuthu S, Chaudhary S, Seshacharyulu P, Rachagani S, Muniyan S, Chirravuri-Venkata R, Atri P, Rauth S, Nimmakayala RK, Siddiqui JA, Gautam SK, Shah A, Natarajan G, Parte S, ... ... Batra SK, et al. Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma. Oncogene. PMID 36271032 DOI: 10.1038/s41388-022-02493-6 |
0.308 |
|
| 2022 |
Nimmakayala RK, Ogunleye AO, Parte S, Krishna Kumar N, Raut P, Varadharaj V, Perumal NK, Nallasamy P, Rauth S, Cox JL, Lele SM, Batra SK, Ponnusamy MP. PAF1 cooperates with YAP1 in metaplastic ducts to promote pancreatic cancer. Cell Death & Disease. 13: 839. PMID 36180487 DOI: 10.1038/s41419-022-05258-x |
0.339 |
|
| 2022 |
Li X, Gulati M, Larson AC, Solheim JC, Jain M, Kumar S, Batra SK. Immune checkpoint blockade in pancreatic cancer: Trudging through the immune desert. Seminars in Cancer Biology. 86: 14-27. PMID 36041672 DOI: 10.1016/j.semcancer.2022.08.009 |
0.339 |
|
| 2022 |
Islam R, Mishra J, Polavaram NS, Bhattacharya S, Hong Z, Bodas S, Sharma S, Bouska A, Gilbreath T, Said AM, Smith LM, Teply BA, Muders MH, Batra SK, Datta K, et al. Neuropilin-2 axis in regulating secretory phenotype of neuroendocrine-like prostate cancer cells and its implication in therapy resistance. Cell Reports. 40: 111097. PMID 35858551 DOI: 10.1016/j.celrep.2022.111097 |
0.355 |
|
| 2022 |
Islam R, Mishra J, Bodas S, Bhattacharya S, Batra SK, Dutta S, Datta K. Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance. Cancer Metastasis Reviews. PMID 35776228 DOI: 10.1007/s10555-022-10048-0 |
0.348 |
|
| 2022 |
Halder S, Parte S, Kshirsagar P, Muniyan S, Nair HB, Batra SK, Seshacharyulu P. The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights. Biochimica Et Biophysica Acta. Reviews On Cancer. 1877: 188737. PMID 35680099 DOI: 10.1016/j.bbcan.2022.188737 |
0.338 |
|
| 2022 |
Muniyan S, Pothuraju R, Seshacharyulu P, Batra SK. Macrophage inhibitory cytokine-1 in cancer: Beyond the cellular phenotype. Cancer Letters. 536: 215664. PMID 35351601 DOI: 10.1016/j.canlet.2022.215664 |
0.361 |
|
| 2022 |
Ganguly K, Shah A, Atri P, Rauth S, Ponnusamy MP, Kumar S, Batra SK. Chemokine-Mucinome Interplay in Shaping the Heterogeneous Tumor Microenvironment in Pancreatic Cancer. Seminars in Cancer Biology. PMID 35346803 DOI: 10.1016/j.semcancer.2022.03.022 |
0.301 |
|
| 2022 |
Bhatia R, Bhyravbhatla N, Kisling A, Li X, Batra SK, Kumar S. Cytokines Chattering in Pancreatic Ductal Adenocarcinoma Tumor Microenvironment. Seminars in Cancer Biology. PMID 35346801 DOI: 10.1016/j.semcancer.2022.03.021 |
0.308 |
|
| 2022 |
Ganguly K, Cox JL, Ghersi D, Grandgenett PM, Hollingsworth MA, Jain M, Kumar S, Batra SK. Mucin 5AC-mediated CD44/ITGB1 clustering mobilizes adipose-derived mesenchymal stem cells to modulate pancreatic cancer stromal heterogeneity. Gastroenterology. PMID 35219699 DOI: 10.1053/j.gastro.2022.02.032 |
0.336 |
|
| 2022 |
Mughees M, Kaushal JB, Sharma G, Wajid S, Batra SK, Siddiqui JA. Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis. Seminars in Cancer Biology. PMID 35181473 DOI: 10.1016/j.semcancer.2022.02.017 |
0.335 |
|
| 2022 |
Saxena S, Molczyk C, Purohit A, Ehrhorn E, Goel P, Prajapati DR, Atri P, Kaur S, Grandgenett PM, Hollingsworth MA, Batra SK, Singh RK. Differential expression profile of CXC-receptor-2 ligands as potential biomarkers in pancreatic ductal adenocarcinoma. American Journal of Cancer Research. 12: 68-90. PMID 35141005 |
0.32 |
|
| 2022 |
Sharma G, Pothuraju R, Kanchan RK, Batra SK, Siddiqui JA. Chemokines network in bone metastasis: Vital regulators of seeding and soiling. Seminars in Cancer Biology. PMID 35124194 DOI: 10.1016/j.semcancer.2022.02.003 |
0.326 |
|
| 2022 |
File N, Carmicheal J, Krasnoslobodtsev AV, Japp NC, Souchek JJ, Chakravarty S, Hollingsworth MA, Sasson AA, Natarajan G, Kshirsagar PG, Jain M, Hayashi C, Junker WM, Kaur S, Batra SK. Substituent Effects Impact Surface Charge and Aggregation of Thiophenol-Labeled Gold Nanoparticles for SERS Biosensors. Biosensors. 12. PMID 35049653 DOI: 10.3390/bios12010025 |
0.751 |
|
| 2021 |
Parte S, Nimmakayala RK, Batra SK, Ponnusamy MP. Acinar to ductal cell trans-differentiation: A prelude to dysplasia and pancreatic ductal adenocarcinoma. Biochimica Et Biophysica Acta. Reviews On Cancer. 1877: 188669. PMID 34915061 DOI: 10.1016/j.bbcan.2021.188669 |
0.329 |
|
| 2021 |
Kshirsagar PG, Gulati M, Junker WM, Aithal A, Spagnol G, Das S, Mallya K, Gautam SK, Kumar S, Sorgen P, Pandey KK, Batra SK, Jain M. Characterization of recombinant β subunit of human MUC4 mucin (rMUC4β). Scientific Reports. 11: 23730. PMID 34887447 DOI: 10.1038/s41598-021-02860-5 |
0.762 |
|
| 2021 |
Cannon A, Thompson CM, Bhatia R, Kandy RRK, Solheim JC, Batra SK, Kumar S. Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies. Biochimica Et Biophysica Acta. Reviews On Cancer. 188628. PMID 34560199 DOI: 10.1016/j.bbcan.2021.188628 |
0.368 |
|
| 2021 |
Ganguly K, Bhatia R, Rauth S, Kisling A, Atri P, Thompson C, Vengoji R, Krishn SR, Shinde D, Thomas V, Kaur S, Mallya K, Cox JL, Kumar S, Batra SK. MUC5AC serves as the nexus for β-catenin/c-Myc interplay to promote glutamine dependency during pancreatic cancer chemoresistance. Gastroenterology. PMID 34534538 DOI: 10.1053/j.gastro.2021.09.017 |
0.353 |
|
| 2021 |
Mehraj U, Ganai RA, Macha MA, Hamid A, Zargar MA, Bhat AA, Nasser MW, Haris M, Batra SK, Alshehri B, Al-Baradie RS, Mir MA, Wani NA. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities. Cellular Oncology (Dordrecht). PMID 34528143 DOI: 10.1007/s13402-021-00634-9 |
0.352 |
|
| 2021 |
Japp NC, Souchek JJ, Sasson AR, Hollingsworth MA, Batra SK, Junker WM. Tumor Biomarker In-Solution Quantification, Standard Production, and Multiplex Detection. Journal of Immunology Research. 2021: 9942605. PMID 34514003 DOI: 10.1155/2021/9942605 |
0.778 |
|
| 2021 |
Nallasamy P, Nimmakayala RK, Karmakar S, Leon F, Seshacharyulu P, Lakshmanan I, Rachagani S, Mallya K, Zhang C, Ly QP, Myers MS, Josh L, Grabow CE, Gautam SK, Kumar S, ... ... Batra SK, et al. Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis. Gastroenterology. PMID 34418441 DOI: 10.1053/j.gastro.2021.08.023 |
0.325 |
|
| 2021 |
Fatima I, Barman S, Uppada J, Chauhan S, Rauth S, Rachagani S, Ponnusamy MP, Smith L, Talmon G, Singh AB, Batra SK, Dhawan P. MASTL regulates EGFR signaling to impact pancreatic cancer progression. Oncogene. PMID 34331012 DOI: 10.1038/s41388-021-01951-x |
0.326 |
|
| 2021 |
Marimuthu S, Rauth S, Ganguly K, Zhang C, Lakshmanan I, Batra SK, Ponnusamy MP. Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression. Cancer Metastasis Reviews. PMID 33813658 DOI: 10.1007/s10555-021-09959-1 |
0.33 |
|
| 2021 |
Poelaert BJ, Knoche SM, Larson AC, Pandey P, Seshacharyulu P, Khan N, Maurer HC, Olive KP, Sheinin Y, Ahmad R, Singh AB, Batra SK, Rachagani S, Solheim JC. Amyloid Precursor-like Protein 2 Expression Increases during Pancreatic Cancer Development and Shortens the Survival of a Spontaneous Mouse Model of Pancreatic Cancer. Cancers. 13. PMID 33810510 DOI: 10.3390/cancers13071535 |
0.404 |
|
| 2021 |
Lakshmanan I, Chaudhary S, Vengoji R, Seshacharyulu P, Rachagani S, Carmicheal J, Jahan R, Atri P, Venkata Ramakanth C, Gupta R, Marimuthu S, Perumal N, Rauth S, Kaur S, Mallya K, ... ... Batra SK, et al. ST6GalNAc-I promotes lung cancer metastasis by altering MUC5AC sialylation. Molecular Oncology. PMID 33792183 DOI: 10.1002/1878-0261.12956 |
0.315 |
|
| 2021 |
Saxena S, Prajapati DR, Goel P, Tomar B, Hayashi Y, Atri P, Rachagani S, Grandgenett PM, Hollingsworth MA, Batra SK, Singh RK. Plexin-B3 Regulates Cellular Motility, Invasiveness, and Metastasis in Pancreatic Cancer. Cancers. 13. PMID 33669221 DOI: 10.3390/cancers13040818 |
0.31 |
|
| 2020 |
Mallya K, Haridas D, Seshacharyulu P, Pothuraju R, Junker WM, Krishn SR, Muniyan S, Vengoji R, Batra SK, Rachagani S. Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model. Biology Open. PMID 34004687 DOI: 10.1242/bio.052878 |
0.794 |
|
| 2020 |
Kaushik G, Seshacharyulu P, Rauth S, Nallasamy P, Rachagani S, Nimmakayala RK, Vengoji R, Mallya K, Chirravuri-Venkata R, Singh AB, Foster JM, Ly QP, Smith LM, Lele SM, Malafa MP, ... ... Batra SK, et al. Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis. Oncogene. PMID 33288882 DOI: 10.1038/s41388-020-01564-w |
0.304 |
|
| 2020 |
Ganguly K, Krishn SR, Rachagani S, Jahan R, Shah A, Nallasamy P, Rauth S, Atri P, Cox JL, Pothuraju R, Smith LM, Ayala S, Evans C, Ponusamy MP, Kumar S, ... ... Batra SK, et al. Secretory mucin 5AC promotes neoplastic progression by augmenting KLF4-mediated pancreatic cancer cell stemness. Cancer Research. PMID 33127746 DOI: 10.1158/0008-5472.CAN-20-1293 |
0.358 |
|
| 2020 |
Mohanty A, Nam A, Pozhitkov A, Yang L, Srivastava S, Nathan A, Wu X, Mambetsariev I, Nelson M, Subbalakshmi AR, Guo L, Nasser MW, Batra SK, Orban J, Jolly MK, et al. A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung Cancer. Iscience. 23: 101496. PMID 32947124 DOI: 10.1016/J.Isci.2020.101496 |
0.369 |
|
| 2020 |
Batra SK, Cannon A, Thompson CM, Maurer C, Atri P, Bhatia R, West S, Ghersi D, Olive KP, Kumar S. CXCR3 and Cognate Ligands Are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32873571 DOI: 10.1158/1078-0432.Ccr-20-1359 |
0.372 |
|
| 2020 |
Muniyan S, Rachagani S, Parte S, Halder S, Seshacharyulu P, Kshirsagar P, Siddiqui JA, Vengoji R, Rauth S, Islam R, Mallya K, Datta K, Xi L, Das A, Teply BA, ... ... Batra SK, et al. Sildenafil potentiates the therapeutic efficacy of docetaxel in advanced prostate cancer by stimulating NO-cGMP signaling. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32847934 DOI: 10.1158/1078-0432.Ccr-20-1569 |
0.329 |
|
| 2020 |
Bhatia R, Thompson C, Ganguly K, Singh S, Batra SK, Kumar S. Alcohol and Smoking Mediated Modulations in Adaptive Immunity in Pancreatitis. Cells. 9. PMID 32796685 DOI: 10.3390/Cells9081880 |
0.324 |
|
| 2020 |
Hoshino A, Kim HS, Bojmar L, Gyan KE, Cioffi M, Hernandez J, Zambirinis CP, Rodrigues G, Molina H, Heissel S, Mark MT, Steiner L, Benito-Martin A, Lucotti S, Di Giannatale A, ... ... Batra SK, et al. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell. PMID 32795414 DOI: 10.1016/J.Cell.2020.07.009 |
0.375 |
|
| 2020 |
Karmakar S, Rauth S, Nallasamy P, Perumal N, Nimmakalaya RK, Leon F, Gupta R, Barkeer S, Venkata RC, Raman V, Rachagani S, Ponnusamy MP, Batra SK. PAF1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions with PHF5A and DDX3. Gastroenterology. PMID 32781084 DOI: 10.1053/J.Gastro.2020.07.053 |
0.444 |
|
| 2020 |
Chaudhary S, Dam V, Ganguly K, Sharma S, Atri P, Chirravuri R, Cox JL, Sayed Z, Jones DT, Ganti AK, Ghersi D, Macha MA, Batra SK. Differential mutation spectrum and immune landscape in African Americans versus whites: A possible determinant to health disparity in head and neck cancer. Cancer Letters. PMID 32738272 DOI: 10.1016/J.Canlet.2020.07.029 |
0.365 |
|
| 2020 |
Mallya K, Haridas D, Seshacharyulu P, Pothuraju R, Junker WM, Krishn SR, Muniyan S, Vengoji R, Batra SK, Rachagani S. Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model. Biology Open. PMID 32709695 DOI: 10.1242/Bio.052878 |
0.805 |
|
| 2020 |
Muniyan S, Xi L, Datta K, Das A, Teply BA, Batra SK, Kukreja RC. Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients. Biochimica Et Biophysica Acta. Reviews On Cancer. 188383. PMID 32535158 DOI: 10.1016/J.Bbcan.2020.188383 |
0.321 |
|
| 2020 |
Liu Y, Kaur S, Huang Y, Fahrmann JF, Rinaudo JA, Hanash SM, Batra SK, Singhi AD, Brand RE, Maitra A, Haab BB. Biomarkers and Strategy to Detect Pre-Invasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32532830 DOI: 10.1158/1055-9965.Epi-20-0161 |
0.374 |
|
| 2020 |
Ganguly K, Rauth S, Marimuthu S, Kumar S, Batra SK. Unraveling mucin domains in cancer and metastasis: when protectors become predators. Cancer Metastasis Reviews. PMID 32488403 DOI: 10.1007/S10555-020-09896-5 |
0.399 |
|
| 2020 |
Awaji M, Saxena S, Wu L, Prajapati DR, Purohit A, Varney ML, Kumar S, Rachagani S, Ly QP, Jain M, Batra SK, Singh RK. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 32453916 DOI: 10.1096/Fj.201902990R |
0.407 |
|
| 2020 |
Chen BT, Chen Z, Ye N, Mambetsariev I, Fricke J, Daniel E, Wang G, Wong CW, Rockne RC, Colen RR, Nasser MW, Batra SK, Holodny AI, Sampath S, Salgia R. Differentiating Peripherally-Located Small Cell Lung Cancer From Non-small Cell Lung Cancer Using a CT Radiomic Approach. Frontiers in Oncology. 10: 593. PMID 32391274 DOI: 10.3389/Fonc.2020.00593 |
0.324 |
|
| 2020 |
Bresalier RS, Grady WM, Markowitz SD, Nielsen HJ, Batra SK, Lampe PD. Biomarkers for Early Detection of Colorectal Cancer:The Early Detection Research Network, a Framework for Clinical Translation. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32299850 DOI: 10.1158/1055-9965.Epi-20-0234 |
0.328 |
|
| 2020 |
Jahan R, Shah A, Kisling SG, Macha MA, Thayer S, Batra SK, Kaur S. Odyssey of trefoil factors in cancer: Diagnostic and therapeutic implications. Biochimica Et Biophysica Acta. Reviews On Cancer. 188362. PMID 32298747 DOI: 10.1016/J.Bbcan.2020.188362 |
0.403 |
|
| 2020 |
Mirzapoiazova T, Pozhitkov A, Nam A, Mambetsariev I, Nelson MS, Tan YC, Zhang K, Raz D, Singhal S, Nasser MW, Kulkarni P, Batra SK, Sattler M, Salgia R. Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell lines. International Journal of Oncology. PMID 32236606 DOI: 10.3892/Ijo.2020.5034 |
0.398 |
|
| 2020 |
Siddiqui JA, Pothuraju R, Jain M, Batra SK, Nasser MW. Advances in cancer cachexia: Intersections between affected organs, mediators, and pharmacological interventions. Biochimica Et Biophysica Acta. Reviews On Cancer. 188359. PMID 32222610 DOI: 10.1016/J.Bbcan.2020.188359 |
0.356 |
|
| 2020 |
Pothuraju R, Krishn SR, Gautam SK, Pai P, Ganguly K, Chaudhary S, Rachagani S, Kaur S, Batra SK. Mechanistic and Functional Shades of Mucins and Associated Glycans in Colon Cancer. Cancers. 12. PMID 32168759 DOI: 10.3390/Cancers12030649 |
0.4 |
|
| 2020 |
Kanchan RK, Perumal N, Atri P, Chirravuri Venkata R, Thapa I, Klinkebiel D, Donson AM, Perry D, Punsoni M, Talmon G, Coulter DW, Boue DR, Snuderl M, Nasser MW, Batra SK, et al. MiR-1253 exerts tumor suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3). Brain Pathology (Zurich, Switzerland). PMID 32145124 DOI: 10.1111/Bpa.12829 |
0.301 |
|
| 2020 |
Pothuraju R, Rachagani S, Krishn SR, Chaudhary S, Nimmakayala RK, Siddiqui JA, Ganguly K, Lakshmanan I, Cox JL, Mallya K, Kaur S, Batra SK. Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance. Molecular Cancer. 19: 37. PMID 32098629 DOI: 10.1186/S12943-020-01156-Y |
0.424 |
|
| 2020 |
Yan Y, Hein AL, Etekpo A, Burchett KM, Lin C, Enke CA, Batra SK, Cowan KH, Ouellette MM. Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. Oncotarget. 11: 304. PMID 32076492 DOI: 10.18632/Oncotarget.27450 |
0.399 |
|
| 2020 |
Gupta R, Leon F, Rauth S, Batra SK, Ponnusamy MP. A Systematic Review on the Implications of O-linked Glycan Branching and Truncating Enzymes on Cancer Progression and Metastasis. Cells. 9. PMID 32075174 DOI: 10.3390/Cells9020446 |
0.396 |
|
| 2020 |
Kanchan RK, Siddiqui JA, Mahapatra S, Batra SK, Nasser MW. microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy. Molecular Cancer. 19: 29. PMID 32059676 DOI: 10.1186/S12943-020-1140-X |
0.301 |
|
| 2020 |
Challa S, Husain K, Kim R, Coppola D, Batra SK, Cheng JQ, Malafa MP. Targeting the IκB Kinase Enhancer and Its Feedback Circuit in Pancreatic Cancer. Translational Oncology. 13: 481-489. PMID 32004866 DOI: 10.1016/J.Tranon.2019.11.009 |
0.408 |
|
| 2020 |
Yokoyama S, Hamada T, Higashi M, Matsuo K, Maemura K, Kurahara H, Horinouchi M, Hiraki T, Sugimoto T, Akahane T, Yonezawa S, Kornmann M, Batra SK, Hollingsworth MA, Tanimoto A. Predicted Prognosis of Pancreatic Cancer Patients by Machine Learning. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31992588 DOI: 10.1158/1078-0432.Ccr-19-1247 |
0.433 |
|
| 2020 |
Gautam SK, Kumar S, Dam V, Ghersi D, Jain M, Batra SK. MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy. Seminars in Immunology. 101391. PMID 31952903 DOI: 10.1016/J.Smim.2020.101391 |
0.389 |
|
| 2020 |
Cannon A, Thompson CM, Atri P, Bhatia R, Kumar S, Batra S. Analysis of associations of CXCR3 ligands with immune microenvironment and aggressiveness in murine and human pancreatic ductal adenocarcinoma. Journal of Clinical Oncology. 38: 762-762. DOI: 10.1200/Jco.2020.38.4_Suppl.762 |
0.369 |
|
| 2020 |
Thompson CM, Cannon A, Kshirsagar P, Bhatia R, Batra S, Kumar S. Clinical significance of MUC4 isoforms in pancreatic cancer patients. Journal of Clinical Oncology. 38: 742-742. DOI: 10.1200/Jco.2020.38.4_Suppl.742 |
0.388 |
|
| 2020 |
Chaudhary S, Pothuraju R, Sayed Z, Jones DT, Batra SK, Macha MA. Abstract A31: Deregulation of NOTCH 1/NR4A2 signaling axis in head and neck cancer pathogenesis Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Aacrahns19-A31 |
0.429 |
|
| 2020 |
Hein AL, Brandquist ND, Ouellette CY, Seshacharyulu P, Enke CA, Ouellette MM, Batra SK, Yan Y. Abstract A44: PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells Molecular Cancer Research. 18. DOI: 10.1158/1557-3125.Hippo19-A44 |
0.457 |
|
| 2020 |
Palanivel C, Gabler BM, Yan Y, Batra SK, Ouellette MM. Abstract A32: The small GTPase Rac1 controls the stability of Yes-Associated Protein (YAP) independently of the LATS1/2 kinases Molecular Cancer Research. 18. DOI: 10.1158/1557-3125.Hippo19-A32 |
0.345 |
|
| 2020 |
Marimuthu S, Lakshmanan I, Muniyan S, Atri P, Jain M, Ponnusamy MP, Batra SK. Abstract 6072: MUC16-Cter cleavage increases the metastatic potential in pancreatic cancer Cancer Research. 80: 6072-6072. DOI: 10.1158/1538-7445.Am2020-6072 |
0.491 |
|
| 2020 |
Leon F, Nimmakayala RK, Chugh S, Gupta R, Rachagani S, Batra SK, Ponnusamy MP. Abstract 6030: Role of immature CD44 o-glycosylation in enrichment of cancer stem cell population for aggressive pancreatic cancer Cancer Research. 80: 6030-6030. DOI: 10.1158/1538-7445.Am2020-6030 |
0.407 |
|
| 2020 |
Shah A, Aithal A, Orzechowski C, Marimuthu S, Kshirsagar P, Ponnusamy MP, Jain M, Batra SK. Abstract 2289: Evaluation of novel genetically engineered anti-MUC16 antibody for therapeutic targeting in pancreatic cancer Immunology. DOI: 10.1158/1538-7445.Am2020-2289 |
0.362 |
|
| 2019 |
Carmicheal J, Patel A, Dalal V, Atri P, Dhaliwal AS, Wittel UA, Malafa MP, Talmon G, Swanson BJ, Singh S, Jain M, Kaur S, Batra SK. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). Biochimica Et Biophysica Acta. Reviews On Cancer. 188318. PMID 31676330 DOI: 10.1016/J.Bbcan.2019.188318 |
0.402 |
|
| 2019 |
Ernani V, Jahan R, Smith LM, Marr AS, Kimbrough SE, Kos ME, Tijerina J, Pivovar S, Lakshmanan I, Ketcham M, Rauth S, Mallya K, Nasser MW, Jain M, Kessinger A, ... Batra SK, et al. A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network study. Cancer Treatment and Research Communications. 22: 100162. PMID 31675535 DOI: 10.1016/J.Ctarc.2019.100162 |
0.376 |
|
| 2019 |
Bhagat TD, Von Ahrens D, Dawlaty M, Zou Y, Baddour J, Achreja A, Zhao H, Yang L, Patel B, Kang C, Choudhary G, Gordon-Mitchell S, Aluri S, Bhattacharyya S, Sahu S, ... ... Batra S, et al. Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts. Elife. 8. PMID 31663852 DOI: 10.7554/Elife.50663 |
0.427 |
|
| 2019 |
West S, Kumar S, Batra SK, Ali H, Ghersi D. Uncovering and characterizing splice variants associated with survival in lung cancer patients. Plos Computational Biology. 15: e1007469. PMID 31652257 DOI: 10.1371/Journal.Pcbi.1007469 |
0.328 |
|
| 2019 |
Mirzapoiazova T, Li H, Nathan A, Srivstava S, Nasser MW, Lennon F, Armstrong B, Mambetsariev I, Chu PG, Achuthan S, Batra SK, Kulkarni P, Salgia R. Monitoring and Determining Mitochondrial Network Parameters in Live Lung Cancer Cells. Journal of Clinical Medicine. 8. PMID 31635288 DOI: 10.3390/Jcm8101723 |
0.306 |
|
| 2019 |
Dalal V, Carmicheal J, Dhaliwal A, Jain M, Kaur S, Batra SK. Radiomics in stratification of pancreatic cystic lesions: Machine learning in action. Cancer Letters. PMID 31629933 DOI: 10.1016/J.Canlet.2019.10.023 |
0.362 |
|
| 2019 |
Parte S, Virant-Klun I, Patankar M, Batra SK, Straughn A, Kakar SS. PTTG1: a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer. Stem Cell Reviews and Reports. PMID 31482269 DOI: 10.1007/S12015-019-09911-5 |
0.425 |
|
| 2019 |
Francois RA, Zhang A, Husain K, Wang C, Hutchinson S, Kongnyuy M, Batra SK, Coppola D, Sebti SM, Malafa MP. Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated down-regulation of c-FLIP. Cancer Cell International. 19: 189. PMID 31367187 DOI: 10.1186/S12935-019-0876-0 |
0.325 |
|
| 2019 |
Zhang W, Fan W, Rachagani S, Zhou Z, Lele SM, Batra SK, Garrison JC. Comparative Study of Subcutaneous and Orthotopic Mouse Models of Prostate Cancer: Vascular Perfusion, Vasculature Density, Hypoxic Burden and BB2r-Targeting Efficacy. Scientific Reports. 9: 11117. PMID 31366895 DOI: 10.1038/S41598-019-47308-Z |
0.367 |
|
| 2019 |
Mambetsariev I, Mirzapoiazova T, Lennon F, Jolly MK, Li H, Nasser MW, Vora L, Kulkarni P, Batra SK, Salgia R. Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial Biology. Journal of Clinical Medicine. 8. PMID 31315252 DOI: 10.3390/Jcm8071038 |
0.379 |
|
| 2019 |
Banerjee K, Gautam SK, Kshirsagar P, Ross KA, Spagnol G, Sorgen P, Wannemuehler MJ, Narasimhan B, Solheim JC, Kumar S, Batra SK, Jain M. Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells. Genes & Cancer. 10: 52-62. PMID 31258832 DOI: 10.18632/Genesandcancer.189 |
0.372 |
|
| 2019 |
Vengoji R, Macha MA, Nimmakayala RK, Rachagani S, Siddiqui JA, Mallya K, Gorantla S, Jain M, Ponnusamy MP, Batra SK, Shonka N. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. Journal of Experimental & Clinical Cancer Research : Cr. 38: 266. PMID 31215502 DOI: 10.1186/S13046-019-1264-2 |
0.354 |
|
| 2019 |
Hollandsworth HM, Lwin TM, Amirfakhri S, Filemoni F, Batra SK, Hoffman RM, Dhawan P, Bouvet M. Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models. The Journal of Surgical Research. 242: 145-150. PMID 31077946 DOI: 10.1016/J.Jss.2019.04.048 |
0.378 |
|
| 2019 |
Jahan R, Ganguly K, Smith LM, Atri P, Carmicheal J, Sheinin Y, Rachagani S, Natarajan G, Brand RE, Macha MA, Grandgenett PM, Kaur S, Batra SK. Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. Ebiomedicine. PMID 30956167 DOI: 10.1016/J.Ebiom.2019.03.056 |
0.385 |
|
| 2019 |
Seshacharyulu P, Rachagani S, Muniyan S, Siddiqui JA, Cruz E, Sharma S, Krishnan R, Killips BJ, Sheinin Y, Lele SM, Smith LM, Talmon GA, Ponnusamy MP, Datta K, Batra SK. FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis. Oncogene. PMID 30914801 DOI: 10.1038/S41388-019-0791-9 |
0.439 |
|
| 2019 |
Hall BR, Cannon A, Thompson C, Santhamma B, Chavez-Riveros A, Bhatia R, Nair HB, Nickisch K, Batra SK, Kumar S. Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma. Genes & Cancer. 10: 1-10. PMID 30899415 DOI: 10.18632/Genesandcancer.184 |
0.382 |
|
| 2019 |
Lei F, Xi X, Batra SK, Bronich TK. Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer. The Journal of Pharmacology and Experimental Therapeutics. PMID 30796131 DOI: 10.1124/Jpet.118.255786 |
0.395 |
|
| 2019 |
Khatri I, Ganguly K, Sharma S, Carmicheal J, Kaur S, Batra SK, Bhasin MK. Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis. Scientific Reports. 9: 123. PMID 30644396 DOI: 10.1038/S41598-018-36328-W |
0.312 |
|
| 2019 |
Bhatia R, Gautam SK, Cannon A, Thompson C, Hall BR, Aithal A, Banerjee K, Jain M, Solheim JC, Kumar S, Batra SK. Cancer-associated mucins: role in immune modulation and metastasis. Cancer Metastasis Reviews. PMID 30618016 DOI: 10.1007/S10555-018-09775-0 |
0.438 |
|
| 2019 |
Chaudhary S, Ganguly K, Muniyan S, Pothuraju R, Sayed Z, Jones DT, Batra SK, Macha MA. Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity. Journal of the National Cancer Institute. PMID 30615137 DOI: 10.1093/Jnci/Djy207 |
0.303 |
|
| 2019 |
Ganguly K, Krishn SR, Jahan R, Atri P, Rachagani S, Rauth S, Xi H, Lu Y, Batra S, Kaur S. Abstract 65: Gel-forming mucin MUC5AC as the nexus for cell-adhesion molecules governing pancreatic cancer aggressiveness and chemoresistance Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-65 |
0.427 |
|
| 2019 |
Atri P, Seshacharyulu P, Rachagani S, Nallasamy P, Rauth S, Kaushik G, Ganguly K, Ghersi D, Ponnusamy MP, Kaur S, Batra SK. Abstract 4804: Pre-clinical development of ISOX; A novel therapy for pancreatic cancer identified utilizing system biology approach(s) Cancer Research. 79: 4804-4804. DOI: 10.1158/1538-7445.Sabcs18-4804 |
0.438 |
|
| 2019 |
Rauth S, Karmakar S, Shah A, Nimmakayala RK, Bhatia R, Muniyan S, Kumar S, Dutta S, Datta K, Batra SK, Ponnusamy MP. Abstract 4438: Role of post translational modification of PAF1/PD2 in gemcitabine resistance of pancreatic cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-4438 |
0.353 |
|
| 2019 |
Karmakar S, Rauth S, Nimmakayala RK, Barkeer S, Nasser MW, Rachagani S, Ghersi D, Ponnusamy MP, Batra SK. Abstract 3679: A novel mechanism for pancreatic cancer stem cell maintenance: PAF1C-independent role of PAF1 Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3679 |
0.436 |
|
| 2019 |
Vengoji R, Macha MA, Nimmakayala R, Rachagani S, Mallya K, Jain M, Ponnusamy MP, Batra SK, Shonka N. Abstract 4684: Afatinib targets glioblastoma stem cells by inhibiting EGFRVIII-cMet co-activation Cancer Research. 79: 4684-4684. DOI: 10.1158/1538-7445.Am2019-4684 |
0.404 |
|
| 2019 |
Fatima I, Chauhan SS, Uppada SB, Talmon GA, Singh AB, Batra SK, Dhawan P. Abstract 2541: Mastl regulates EGFR signaling to promote pancreatic cancer progression Cancer Research. 79: 2541-2541. DOI: 10.1158/1538-7445.Am2019-2541 |
0.5 |
|
| 2019 |
Gautam SK, Kanchan R, Atri P, Siddiqui J, Rauth S, Mahapatra S, Jain M, Moorthy PP, Salgia R, Band V, Batra SK, Nasser MW. Abstract 2017: Blocking ErbB-c-Met-FAK signaling axis suppresses brain metastasis of breast cancer Cancer Research. 79: 2017-2017. DOI: 10.1158/1538-7445.Am2019-2017 |
0.369 |
|
| 2019 |
Awaji M, Varney M, Purohit A, Wu L, Saxena S, Kumar S, Batra SK, Singh RK. Abstract 1982: Sustained CXCR2 signaling promotes secretory phenotype in cancer-associated fibroblasts of pancreatic cancer via activation of NFkB Cancer Research. 79: 1982-1982. DOI: 10.1158/1538-7445.Am2019-1982 |
0.463 |
|
| 2019 |
Saxena S, Tomar B, Wu L, Awaji M, Rachagani S, Ouellette MJ, Batra SK, Dave BJ, Singh RK. Abstract 1725: Mutationally activated KRAS(G12D) upregulates the expression of axonal guidance cue Semaphorin-5A in pancreatic cancer Cancer Research. 79: 1725-1725. DOI: 10.1158/1538-7445.Am2019-1725 |
0.442 |
|
| 2018 |
Etekpo A, Alghawalby A, Alghawalby M, Soliman AS, Hablas A, Chen B, Batra S, Soliman GA. Differences in Expression in Pancreatic Cancers and Pancreatic Cysts in Egypt. Journal of Carcinogenesis & Mutagenesis. 9. PMID 34164227 DOI: 10.4172/2157-2518.1000312 |
0.353 |
|
| 2018 |
Uz M, Kalaga M, Pothuraju R, Ju J, Junker WM, Batra SK, Mallapragada S, Rachagani S. Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 294: 237-246. PMID 30576747 DOI: 10.1016/J.Jconrel.2018.12.031 |
0.762 |
|
| 2018 |
Pothuraju R, Rachagani S, Junker WM, Chaudhary S, Saraswathi V, Kaur S, Batra SK. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting. Journal of Experimental & Clinical Cancer Research : Cr. 37: 319. PMID 30567565 DOI: 10.1186/S13046-018-0963-4 |
0.771 |
|
| 2018 |
Carmicheal J, Hayashi C, Huang X, Liu L, Lu Y, Krasnoslobodtsev A, Lushnikov A, Kshirsagar PG, Patel A, Jain M, Lyubchenko YL, Lu Y, Batra SK, Kaur S. Label-free characterization of exosome via surface enhanced Raman spectroscopy for the early detection of pancreatic Cancer. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 30550805 DOI: 10.1016/J.Nano.2018.11.008 |
0.472 |
|
| 2018 |
Vengoji R, Ponnusamy MP, Rachagani S, Mahapatra S, Batra SK, Shonka N, Macha MA. Novel Therapies Hijack the Blood Brain Barrier to Eradicate Glioblastoma Cancer Stem Cells. Carcinogenesis. PMID 30475990 DOI: 10.1093/Carcin/Bgy171 |
0.379 |
|
| 2018 |
Barkeer S, Chugh S, Karmakar S, Kaushik G, Rauth S, Rachagani S, Batra SK, Ponnusamy MP. Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells. Bmc Cancer. 18: 1157. PMID 30466404 DOI: 10.1186/S12885-018-5074-2 |
0.43 |
|
| 2018 |
Nimmakayala RK, Batra SK, Ponnusamy MP. Unraveling the journey of cancer stem cells from origin to metastasis. Biochimica Et Biophysica Acta. Reviews On Cancer. 1871: 50-63. PMID 30419314 DOI: 10.1016/J.Bbcan.2018.10.006 |
0.426 |
|
| 2018 |
Carmicheal J, Kaur S, Batra SK, Ganti AK. Hunting for transcription factors: STAT3 decoy in non-small cell lung cancer. Translational Lung Cancer Research. 7: S254-S257. PMID 30393616 DOI: 10.21037/Tlcr.2018.09.06 |
0.357 |
|
| 2018 |
Wang J, Mirzapoiazova T, Carol Tan YH, Pang KM, Pozhitkov A, Wang Y, Wang Y, Mambetsariev B, Wang E, Nasser MW, Batra SK, Raz D, Reckamp K, Kulkarni P, Zheng Y, et al. Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma. Cancer Biology & Therapy. 1-10. PMID 30311833 DOI: 10.1080/15384047.2018.1472193 |
0.389 |
|
| 2018 |
Hall BR, Cannon A, Atri P, Wichman CS, Smith LM, Kumar S, Batra SK, Wang H, Ganti AK, Sasson AR, Are C. A Comparative Analysis of Survival and Funding Discrepancies in Cancers with High Mortality. Annals of Surgery. PMID 30188400 DOI: 10.1097/Sla.0000000000003042 |
0.325 |
|
| 2018 |
Parte SC, Batra SK, Kakar SS. Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors. Journal of Ovarian Research. 11: 69. PMID 30121075 DOI: 10.1186/S13048-018-0439-3 |
0.422 |
|
| 2018 |
Datta K, Roy S, Bag AK, Dutta S, Polavaram NS, Islam R, Schellenburg S, Banwait JK, Guda C, Ran S, Hollingsworth MA, Singh RK, Talmadge JE, Muders MH, Batra SK. Macrophage-derived Neuropilin-2 exhibits novel tumor-promoting functions. Cancer Research. PMID 30111533 DOI: 10.1158/0008-5472.Can-18-0562 |
0.335 |
|
| 2018 |
Cannon A, Thompson C, Hall BR, Jain M, Kumar S, Batra SK. Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential. Genes & Cancer. 9: 78-86. PMID 30108679 DOI: 10.18632/Genesandcancer.171 |
0.398 |
|
| 2018 |
Chugh S, Barkeer S, Rachagani S, Nimmakayala RK, Perumal N, Pothuraju R, Atri P, Mahapatra S, Thapa I, Talmon GA, Smith LM, Yu X, Neelamegham S, Fu J, Xia L, ... ... Batra SK, et al. Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice. Gastroenterology. PMID 30086262 DOI: 10.1053/J.Gastro.2018.08.007 |
0.312 |
|
| 2018 |
Uppada SB, Gowrikumar S, Ahmad R, Kumar B, Szeglin B, Chen X, Smith JJ, Batra SK, Singh AB, Dhawan P. MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling. Molecular Cancer. 17: 111. PMID 30068336 DOI: 10.1186/S12943-018-0848-3 |
0.454 |
|
| 2018 |
Barkeer S, Chugh S, Batra SK, Ponnusamy MP. Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis. Neoplasia (New York, N.Y.). 20: 813-825. PMID 30015157 DOI: 10.1016/J.Neo.2018.06.001 |
0.451 |
|
| 2018 |
Aithal A, Rauth S, Kshirsagar P, Shah A, Lakshmanan I, Junker WM, Jain M, Ponnusamy MP, Batra SK. MUC16 as a Novel Target for Cancer Therapy. Expert Opinion On Therapeutic Targets. PMID 29999426 DOI: 10.1080/14728222.2018.1498845 |
0.787 |
|
| 2018 |
Nimmakayala RK, Seshacharyulu P, Lakshmanan I, Rachagani S, Chugh S, Karmakar S, Rauth S, Vengoji R, Atri P, Talmon GA, Lele SM, Smith LM, Thapa I, Bastola D, Ouellette MM, ... Batra SK, et al. Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1. Gastroenterology. PMID 29864419 DOI: 10.1053/J.Gastro.2018.05.041 |
0.416 |
|
| 2018 |
Jahan R, Macha MA, Rachaghani S, Das S, Smith LM, Kaur S, Batra SK. Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway. Biochimica Et Biophysica Acta. PMID 29777904 DOI: 10.1016/J.Bbadis.2018.05.008 |
0.425 |
|
| 2018 |
Vengoji R, Macha MA, Batra SK, Shonka NA. Natural products: a hope for glioblastoma patients. Oncotarget. 9: 22194-22219. PMID 29774132 DOI: 10.18632/Oncotarget.25175 |
0.344 |
|
| 2018 |
Kaushik G, Ponnusamy MP, Batra SK. Current Status of 3-D Organoids as Pre-Clinical Models. Stem Cells (Dayton, Ohio). PMID 29770526 DOI: 10.1002/Stem.2852 |
0.32 |
|
| 2018 |
Hall BR, Cannon A, Atri P, Wichman CS, Smith LM, Ganti AK, Are C, Sasson AR, Kumar S, Batra SK. Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years. Oncotarget. 9: 19396-19405. PMID 29721211 DOI: 10.18632/Oncotarget.25036 |
0.366 |
|
| 2018 |
Aithal A, Junker WM, Kshirsagar P, Das S, Kaur S, Orzechowski C, Gautam SK, Jahan R, Sheinin YM, Lakshmanan I, Ponnusamy MP, Batra SK, Jain M. Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer. Plos One. 13: e0193907. PMID 29708979 DOI: 10.1371/Journal.Pone.0193907 |
0.795 |
|
| 2018 |
Mohapatra SS, Batra SK, Bharadwaj S, Bouvet M, Cosman B, Goel A, Jogunoori W, Kelley MJ, Mishra L, Mishra B, Mohapatra S, Patel B, Pisegna JR, Raufman JP, Rao S, et al. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions. Digestive Diseases and Sciences. PMID 29572615 DOI: 10.1007/S10620-018-5000-0 |
0.362 |
|
| 2018 |
Saxena S, Hayashi Y, Wu L, Awaji M, Atri P, Varney ML, Purohit A, Rachagani S, Batra SK, Singh RK. Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis. Oncotarget. 9: 5931-5943. PMID 29464045 DOI: 10.18632/Oncotarget.23644 |
0.484 |
|
| 2018 |
Ingersoll MA, Chou YW, Lin JS, Yuan TC, Miller D, Xie Y, Tu Y, Oberley-Deegan RE, Batra SK, Lin MF. p66Shc regulates migration of castration-resistant prostate cancer cells. Cellular Signalling. PMID 29462661 DOI: 10.1016/J.Cellsig.2018.02.008 |
0.412 |
|
| 2018 |
Qazi AK, Siddiqui JA, Jahan R, Chaudhary S, Walker LA, Syed Z, Jones DT, Batra SK, Macha MA. Emerging Therapeutic Potential of Graviola and its Constituents in Cancers. Carcinogenesis. PMID 29462271 DOI: 10.1093/Carcin/Bgy024 |
0.371 |
|
| 2018 |
Krishn SR, Ganguly K, Kaur S, Batra SK. Ramifications of Secreted Mucin MUC5AC in Malignant Journey: A Holistic View. Carcinogenesis. PMID 29415129 DOI: 10.1093/Carcin/Bgy019 |
0.367 |
|
| 2018 |
Karmakar S, Dey P, Vaz AP, Bhaumik SR, Ponnusamy MP, Batra SK. PD2/PAF1 at the Crossroads of the Cancer Network. Cancer Research. PMID 29311159 DOI: 10.1158/0008-5472.Can-17-2175 |
0.562 |
|
| 2018 |
Kanteti R, Mirzapoiazova T, Riehm JJ, Dhanasingh I, Mambetsariev B, Wang J, Kulkarni P, Kaushik G, Seshacharyulu P, Ponnusamy MP, Kindler HL, Nasser MW, Batra SK, Salgia R. Focal Adhesion Kinase a Potential Therapeutic Target for Pancreatic Cancer and Malignant Pleural Mesothelioma. Cancer Biology & Therapy. 0. PMID 29303405 DOI: 10.1080/15384047.2017.1416937 |
0.455 |
|
| 2018 |
Etekpo A, Alghawalby A, Alghawalby M, Soliman AS, Hablas A, Chen B, Batra S, Soliman GA. Differences in MUC4 Expression in Pancreatic Cancers and Pancreatic Cysts in Egypt Journal of Carcinogenesis & Mutagenesis. 9. DOI: 10.4172/2157-2518.1000312 |
0.462 |
|
| 2018 |
Awaji M, Varney M, Purohit A, Batra S, Singh R. Abstract 5085: CXCR2 signaling in pancreatic cancer induces a tumor supporting inflammatory phenotype of the cancer-associated fibroblasts Cancer Research. 78: 5085-5085. DOI: 10.1158/1538-7445.Am2018-5085 |
0.43 |
|
| 2018 |
Palanivel C, Gabler B, Yan Y, Batra SK, Ouellette MM. Abstract 4366: The small GTPase Rac1 controls the stability of the Yes-associated protein 1 (YAP1) independently of the LATS1/2 kinases and SCF-βTRCP ubiquitin ligase Cancer Research. 78: 4366-4366. DOI: 10.1158/1538-7445.Am2018-4366 |
0.359 |
|
| 2018 |
Orzechowski C, Aithal A, Junker W, Kshirsagar P, Batra S, Jain M. Abstract 3829: Generation and characterization of novel antibodies against the β subunit of MUC4 Immunology. 78: 3829-3829. DOI: 10.1158/1538-7445.Am2018-3829 |
0.802 |
|
| 2018 |
Saxena S, Hayashi Y, Rachagani S, Batra SK, Singh RK. Abstract 3021: Plexin-B3 regulates cellular motility, invasiveness and metastasis in pancreatic cancer Cancer Research. 78: 3021-3021. DOI: 10.1158/1538-7445.Am2018-3021 |
0.429 |
|
| 2018 |
Chaudhary S, Pothuraju R, Atri P, Rachagani S, Batra SK, Macha MA. Abstract 1909: NR4A2 role in head and neck cancer: Mechanistic and functional analysis Cancer Research. 78: 1909-1909. DOI: 10.1158/1538-7445.Am2018-1909 |
0.405 |
|
| 2017 |
Banerjee K, Kumar S, Ross KA, Gautam S, Poelaert B, Nasser MW, Aithal A, Bhatia R, Wannemuehler MJ, Narasimhan B, Solheim JC, Batra SK, Jain M. Emerging trends in the immunotherapy of pancreatic cancer. Cancer Letters. PMID 29242097 DOI: 10.1016/J.Canlet.2017.12.012 |
0.411 |
|
| 2017 |
Chen S, Boda SK, Batra SK, Li X, Xie J. Emerging Roles of Electrospun Nanofibers in Cancer Research. Advanced Healthcare Materials. PMID 29210522 DOI: 10.1002/Adhm.201701024 |
0.413 |
|
| 2017 |
Karmakar S, Kaushik G, Nimmakayala R, Rachagani S, Ponnusamy MP, Batra SK. MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention. Seminars in Cancer Biology. PMID 29199014 DOI: 10.1016/J.Semcancer.2017.11.020 |
0.318 |
|
| 2017 |
Burchett KM, Etekpo A, Batra SK, Yan Y, Ouellette MM. Inhibitors of telomerase and poly(ADP-ribose) polymerases synergize to limit the lifespan of pancreatic cancer cells. Oncotarget. 8: 83754-83767. PMID 29137380 DOI: 10.18632/Oncotarget.19410 |
0.416 |
|
| 2017 |
Parte SC, Smolenkov AS, Batra SK, Ratajczak MZ, Kakar SS. Ovarian Cancer Stem Cells: Unravelling a Germline Connection. Stem Cells and Development. PMID 29078734 DOI: 10.1089/Scd.2017.0153 |
0.443 |
|
| 2017 |
Roy S, Bag AK, Singh RK, Talmadge JE, Batra SK, Datta K. Multifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy. Frontiers in Immunology. 8: 1228. PMID 29067024 DOI: 10.3389/Fimmu.2017.01228 |
0.364 |
|
| 2017 |
Ferdoush J, Karmakar S, Barman P, Kaja A, Uprety B, Batra SK, Bhaumik SR. Ubiquitin-proteasome system regulation of an evolutionarily conserved RNA polymerase II-associated factor 1 involved in pancreatic oncogenesis. Biochemistry. PMID 29023102 DOI: 10.1021/Acs.Biochem.7B00865 |
0.435 |
|
| 2017 |
Tan YC, Mirzapoiazova T, Won BM, Zhu L, Srivastava MK, Vokes EE, Husain AN, Batra SK, Sharma S, Salgia R. Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL. Scientific Reports. 7: 9192. PMID 28835699 DOI: 10.1038/S41598-017-09078-4 |
0.391 |
|
| 2017 |
Ahmad R, Kumar B, Chen Z, Chen X, Müller D, Lele SM, Washington MK, Batra SK, Dhawan P, Singh AB. Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/β-catenin signaling. Oncogene. PMID 28783170 DOI: 10.1038/Onc.2017.259 |
0.403 |
|
| 2017 |
Yokoyama S, Higashi M, Tsutsumida H, Wakimoto J, Hamada T, Wiest E, Matsuo K, Kitazono I, Goto Y, Guo X, Hamada T, Yamada S, Hiraki T, Yonezawa S, Batra SK, et al. TET1-mediated DNA hypomethylation regulates the expression of MUC4 in lung cancer. Genes & Cancer. 8: 517-527. PMID 28680536 DOI: 10.18632/Genesandcancer.139 |
0.366 |
|
| 2017 |
Honjo K, Hiraki T, Higashi M, Noguchi H, Nomoto M, Yoshimura T, Batra SK, Yonezawa S, Semba I, Nakamura N, Tanimoto A, Yamada S. Immunohistochemical expression profiles of mucin antigens in salivary gland mucoepidermoid carcinoma: MUC4- and MUC6-negative expression predicts a shortened survival in the early postoperative phase. Histology and Histopathology. 11913. PMID 28649694 DOI: 10.14670/Hh-11-913 |
0.384 |
|
| 2017 |
Gautam SK, Kumar S, Cannon A, Hall B, Bhatia R, Nasser MW, Mahapatra S, Batra S, Jain M. MUC4 Mucin- A Therapeutic Target for Pancreatic Ductal Adenocarcinoma. Expert Opinion On Therapeutic Targets. PMID 28460571 DOI: 10.1080/14728222.2017.1323880 |
0.402 |
|
| 2017 |
Macha MA, Rachagani S, Qazi AK, Jahan R, Gupta S, Patel A, Seshacharyulu P, Lin C, Li S, Wang S, Verma V, Kishida S, Kishida M, Nakamura N, Kibe T, ... ... Batra SK, et al. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells. Oncotarget. 8: 20961-20973. PMID 28423495 DOI: 10.18632/Oncotarget.15468 |
0.427 |
|
| 2017 |
Seshacharyulu P, Baine MJ, Souchek JJ, Menning M, Kaur S, Yan Y, Ouellette MM, Jain M, Lin C, Batra SK. Biological determinants of radioresistance and their remediation in pancreatic cancer. Biochimica Et Biophysica Acta. PMID 28249796 DOI: 10.1016/J.Bbcan.2017.02.003 |
0.81 |
|
| 2017 |
Lakshmanan I, Salfity S, Seshacharyulu P, Rachagani S, Thomas A, Das S, Majhi PD, Nimmakayala RK, Vengoji R, Lele SM, Ponnusamy MP, Batra SK, Ganti AK. MUC16 regulates TSPYL5 for lung cancer cell growth and chemoresistance by suppressing p53. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28196872 DOI: 10.1158/1078-0432.Ccr-16-2530 |
0.406 |
|
| 2017 |
Karmakar S, Seshacharyulu P, Lakshmanan I, Vaz AP, Chugh S, Sheinin YM, Mahapatra S, Batra SK, Ponnusamy MP. hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells. Oncotarget. PMID 28122356 DOI: 10.18632/Oncotarget.14775 |
0.322 |
|
| 2017 |
Kshirsagar P, Rachagani S, Seshacharyulu P, Muniyan S, Mahato R, Batra SK, Jain M. Abstract LB-331: Advanced DNA-gold nanoprobe-based direct and sensitive quantification of novel microRNAs in prostate cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-331 |
0.305 |
|
| 2017 |
Hayashi C, Carmicheal J, Krasnoslobodtsev A, Haung Y, Brand RE, Batra SK, Kaur S. Abstract LB-244: Implication of secretory mucin MUC5AC and its glycan modification for detection of pancreatic cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-244 |
0.423 |
|
| 2017 |
Awaji M, Varney M, Purohit A, Batra SK, Singh RK. Abstract 942: CXCR2 acts as a checkpoint regulator of the pancreatic stellate cells activity within pancreatic cancer tumor microenvironment Cancer Research. 77: 942-942. DOI: 10.1158/1538-7445.Am2017-942 |
0.378 |
|
| 2017 |
Jahan R, Kaur S, Macha MA, Sheinin Y, Smith L, Meza J, Batra SK. Abstract 719: Pathobiological implications of Trefoil Factors in the progression and metastasis of pancreatic cancer Cancer Research. 77: 719-719. DOI: 10.1158/1538-7445.Am2017-719 |
0.45 |
|
| 2017 |
Chugh S, Rachagani S, Yu X, Neelamegham S, Xia L, Ouellette MM, Ponnusamy MP, Batra SK. Abstract 5801: Loss of core 1 β1,3-galactosyltransferase (C1GALT1) in pancreatic cancer leads to altered mucin glycosylation and increased tumor aggressiveness Cancer Research. 77: 5801-5801. DOI: 10.1158/1538-7445.Am2017-5801 |
0.383 |
|
| 2017 |
Saxena S, Purohit A, Batra SK, Singh RK. Abstract 5797: Semaphorin 5A preserves epithelial phenotype in pancreatic cancer cells by regulating cross-talk between Wnt and TGF-β signaling Cancer Research. 77: 5797-5797. DOI: 10.1158/1538-7445.Am2017-5797 |
0.421 |
|
| 2017 |
Hall B, Santhamma B, Cannon A, Bhatia R, Kumar S, Are C, Nair H, Nickisch K, Batra S. Abstract 5792: Development of cell line derived organoids to evaluate stroma targeted therapies in pancreatic cancer Cancer Research. 77: 5792-5792. DOI: 10.1158/1538-7445.Am2017-5792 |
0.431 |
|
| 2017 |
Cannon AC, Kumar S, Hall B, Bhatia R, Singh R, Batra S. Abstract 3912: Pancreatic cancer cell interaction with platelets impedes cell cycle progression and increases viability Cancer Research. 77: 3912-3912. DOI: 10.1158/1538-7445.Am2017-3912 |
0.417 |
|
| 2017 |
Carter K, Parte S, Batra SK, Ratajczak MZ, Kakar SS. Abstract 3895: Verrucarin J targets both cancer cells and cancer stem cells Cancer Research. 77: 3895-3895. DOI: 10.1158/1538-7445.Am2017-3895 |
0.423 |
|
| 2017 |
Banerjee K, Gautam S, Nasser WM, Kshirsagar P, Ross K, Spagnol G, Aithal A, Sorgen P, Batra SK, Kumar S, Narasimhan B, Jain M. Abstract 3678: Muc4 nanovaccine and checkpoint blockade based combination immunotherapy for pancreatic cancer Cancer Research. 77: 3678-3678. DOI: 10.1158/1538-7445.Am2017-3678 |
0.424 |
|
| 2017 |
Lakshmanan I, Rachagani S, Ponnusamy M, Chugh S, Dutta S, Muniyan S, Batra S, Kishore A. Abstract 2825: Gene expression profile in genetically engineered mouse model of lung cancer correlates with that in human lung adenocarcinoma Cancer Research. 77: 2825-2825. DOI: 10.1158/1538-7445.Am2017-2825 |
0.308 |
|
| 2017 |
Gupta S, Rachagani S, Kumar S, Batra SK, Jain M. Abstract 2691: Cigarette smoke induced upregulation of endothelin axis in the initiation of pancreatic cancer Immunology. 77: 2691-2691. DOI: 10.1158/1538-7445.Am2017-2691 |
0.35 |
|
| 2017 |
Ahmad R, kumar B, Chen Z, Chen S, Muller D, Lele SM, Washington MK, Batra SK, Dhawan P, Singh AB. Abstract 1342: Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy Cancer Research. 77: 1342-1342. DOI: 10.1158/1538-7445.Am2017-1342 |
0.414 |
|
| 2017 |
Vengoji R, Rachagani S, Gupta S, Mallya K, Jain M, Ponnusamy M, Batra S, Shonka N. Abstract 1104: Novel specific RTK targeting of EGFR/FAK axis in glioblastoma invasion Cancer Research. 77: 1104-1104. DOI: 10.1158/1538-7445.Am2017-1104 |
0.346 |
|
| 2016 |
Kaur S, Smith LM, Patel A, Menning M, Watley DC, Malik SS, Krishn SR, Mallya K, Aithal A, Sasson AR, Johansson SL, Jain M, Singh S, Guha S, Are C, ... ... Batra SK, et al. A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study. The American Journal of Gastroenterology. PMID 27845339 DOI: 10.1038/Ajg.2016.482 |
0.386 |
|
| 2016 |
Kumar S, Cruz E, Joshi S, Patel A, Jahan R, Batra SK, Jain M. Genetic Variants of Mucins: Unexplored Conundrum. Carcinogenesis. PMID 27838635 DOI: 10.1093/Carcin/Bgw120 |
0.42 |
|
| 2016 |
Krishn SR, Kaur S, Sheinin YM, Smith LM, Gautam SK, Patel A, Jain M, Juvvigunta V, Pai P, Lazenby AJ, Roy HK, Batra SK. Mucins and associated O-glycans based immunoprofile for stratification of colorectal polyps: clinical implication for improved colon surveillance. Oncotarget. PMID 27705923 DOI: 10.18632/Oncotarget.12347 |
0.314 |
|
| 2016 |
Ingersoll MA, Miller DR, Martinez O, Wakefield CB, Hsieh KC, Simha MV, Kao CL, Chen HT, Batra SK, Lin MF. Statin Derivatives as Therapeutic Agents for Castration-Resistant Prostate Cancer. Cancer Letters. PMID 27687622 DOI: 10.1016/J.Canlet.2016.09.008 |
0.382 |
|
| 2016 |
Hiraki T, Yamada S, Higashi M, Hatanaka K, Yokoyama S, Kitazono I, Goto Y, Kirishima M, Batra SK, Yonezawa S, Tanimoto A. Immunohistochemical expression of mucin antigens in gallbladder adenocarcinoma: MUC1-positive and MUC2-negative expression Is associated with vessel invasion and shortened survival. Histology and Histopathology. 11824. PMID 27672051 DOI: 10.14670/Hh-11-824 |
0.385 |
|
| 2016 |
Pai P, Rachagani S, Dhawan P, Sheinin YM, Macha MA, Qazi AK, Chugh S, Ponnusamy MP, Mallya K, Pothuraju R, Batra SK. MUC4 is negatively regulated through the Wnt/β-catenin pathway via the Notch effector Hath1 in colorectal cancer. Genes & Cancer. 7: 154-68. PMID 27551331 DOI: 10.18632/Genesandcancer.108 |
0.337 |
|
| 2016 |
Muniyan S, Haridas D, Chugh S, Rachagani S, Lakshmanan I, Gupta S, Seshacharyulu P, Smith LM, Ponnusamy MP, Batra SK. MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism. Genes & Cancer. 7: 110-24. PMID 27382435 DOI: 10.18632/Genesandcancer.104 |
0.461 |
|
| 2016 |
Yokoyama S, Higashi M, Kitamoto S, Oeldorf M, Knippschild U, Kornmann M, Maemura K, Kurahara H, Wiest E, Hamada T, Kitazono I, Goto Y, Tasaki T, Hiraki T, Hatanaka K, ... ... Batra SK, et al. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas. Oncotarget. PMID 27283771 DOI: 10.18632/Oncotarget.9924 |
0.369 |
|
| 2016 |
Wang Y, Kumar S, Rachagani S, Sajja BR, Xie Y, Hang Y, Jain M, Li J, Boska MD, Batra SK, Oupický D. Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis. Biomaterials. 101: 108-120. PMID 27267632 DOI: 10.1016/J.Biomaterials.2016.05.042 |
0.407 |
|
| 2016 |
Suklabaidya S, Das B, Ali SA, Jain S, Swaminathan S, Mohanty AK, Panda SK, Dash P, Chakraborty S, Batra SK, Senapati S. Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia. Oncotarget. PMID 27259232 DOI: 10.18632/Oncotarget.9729 |
0.423 |
|
| 2016 |
Chugh S, Meza J, Sheinin YM, Ponnusamy MP, Batra SK. Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation. British Journal of Cancer. PMID 27187683 DOI: 10.1038/Bjc.2016.116 |
0.342 |
|
| 2016 |
Joshi S, Cruz E, Rachagani S, Guha S, Brand RE, Ponnusamy MP, Kumar S, Batra SK. Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer. Molecular Oncology. PMID 27185392 DOI: 10.1016/J.Molonc.2016.04.007 |
0.42 |
|
| 2016 |
Hein AL, Post CM, Sheinin YM, Lakshmanan I, Natarajan A, Enke CA, Batra SK, Ouellette MM, Yan Y. RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment. Oncogene. PMID 27181206 DOI: 10.1038/Onc.2016.163 |
0.421 |
|
| 2016 |
Joshi S, Kumar S, Ponnusamy MP, Batra SK. Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival. Oncogene. PMID 27109098 DOI: 10.1038/Onc.2016.119 |
0.411 |
|
| 2016 |
Dutta S, Roy S, Polavaram NS, Baretton GB, Muders MH, Batra S, Datta K. NRP2 transcriptionally regulates its downstream effector WDFY1. Scientific Reports. 6: 23588. PMID 27026195 DOI: 10.1038/Srep23588 |
0.446 |
|
| 2016 |
Kanteti R, Batra SK, Lennon FE, Salgia R. FAK and paxillin, two potential targets in pancreatic cancer. Oncotarget. PMID 26980710 DOI: 10.18632/Oncotarget.8040 |
0.451 |
|
| 2016 |
Krishn SR, Kaur S, Smith LM, Johansson SL, Jain M, Patel A, Gautam SK, Hollingsworth MA, Mandel U, Clausen H, Lo WC, Fan WL, Manne U, Batra SK. Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer. Cancer Letters. PMID 26898938 DOI: 10.1016/J.Canlet.2016.02.016 |
0.395 |
|
| 2016 |
Hein AL, Seshacharyulu P, Rachagani S, Sheinin YM, Ouellette MM, Ponnusamy MP, Mumby MC, Batra SK, Yan Y. PR55α subunit of protein phosphatase 2A supports the tumorigenic and metastatic potential of pancreatic cancer cells by sustaining hyperactive oncogenic signaling. Cancer Research. PMID 26893480 DOI: 10.1158/0008-5472.Can-15-2119 |
0.515 |
|
| 2016 |
Pandey P, Sliker B, Peters HL, Tuli A, Herskovitz J, Smits K, Purohit A, Singh RK, Dong J, Batra SK, Coulter DW, Solheim JC. Amyloid precursor protein and amyloid precursor-like protein 2 in cancer. Oncotarget. PMID 26840089 DOI: 10.18632/Oncotarget.7103 |
0.372 |
|
| 2016 |
Purohit A, Varney M, Rachagani S, Ouellette MM, Batra SK, Singh RK. CXCR2 signaling regulates KRAS (G12D)-induced autocrine growth of pancreatic cancer. Oncotarget. PMID 26771140 DOI: 10.18632/Oncotarget.6906 |
0.458 |
|
| 2016 |
Pai P, Rachagani S, Dhawan P, Batra SK. Mucins and Wnt/β-catenin Signaling in Gastrointestinal Cancers: An Unholy Nexus. Carcinogenesis. PMID 26762229 DOI: 10.1093/Carcin/Bgw005 |
0.335 |
|
| 2016 |
Lakshmanan I, Rachagani S, Hauke R, Krishn SR, Paknikar S, Seshacharyulu P, Karmakar S, Nimmakayala RK, Kaushik G, Johansson SL, Carey GB, Ponnusamy MP, Kaur S, Batra SK, Ganti AK. MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling. Oncogene. PMID 26751774 DOI: 10.1038/Onc.2015.478 |
0.381 |
|
| 2016 |
Patel A, Kaur S, Smith L, Are C, Batra S. Diagnostic potential of mucins in pancreatic juice for pancreatic cancer. Journal of Clinical Oncology. 34: 222-222. DOI: 10.1200/Jco.2016.34.4_Suppl.222 |
0.316 |
|
| 2016 |
Ingersoll MA, Muniyan S, Lin F, Yuan T, Chou Y, Batra SK, Lin M. Abstract 5069: p66Shc regulates the migration of castration-resistant prostate cancer Cancer Research. 76: 5069-5069. DOI: 10.1158/1538-7445.Am2016-5069 |
0.329 |
|
| 2016 |
Cruz E, Batra SK. Abstract 4555: Identification of bone morphogenetic protein 2 splice variant in pancreatic cancer reveals cross-talk between endocytic and autophagy pathways Cancer Research. 76: 4555-4555. DOI: 10.1158/1538-7445.Am2016-4555 |
0.434 |
|
| 2016 |
Dutta S, Roy S, Polavaram NS, Stanton M, Batra S, Muders MH, Datta K. Abstract 3526: Novel function of NRP2 in therapy resistant metastatic cancer Cancer Research. 76: 3526-3526. DOI: 10.1158/1538-7445.Am2016-3526 |
0.349 |
|
| 2016 |
Aithal A, Junker W, Kaur S, Das S, Kshirsagar P, Rachagani S, Mallya K, Jain M, Batra SK. Abstract 2978: Characterization of novel antibodies for understanding MUC16 cleavage and its pathological implications in cancer Cancer Research. 76: 2978-2978. DOI: 10.1158/1538-7445.Am2016-2978 |
0.813 |
|
| 2016 |
Karmakar S, Seshacharyulu P, Vaz AP, Lakshmanan I, Ponnusamy MP, Batra SK. Abstract 2495: hPaf1/PD2 interacts with OCT3/4 in maintenance of the self-renewal process of ovarian cancer stem cells Cancer Research. 76: 2495-2495. DOI: 10.1158/1538-7445.Am2016-2495 |
0.414 |
|
| 2016 |
Nimmakayala R, Seshacharyulu P, Chugh S, Lakshmanan I, Rachagani S, Batra SK, MPP. Abstract 2490: Smoking enriches cancer stem cell population and activates Sox9 through NF-kB signaling in pancreatic ductal adenocarcinoma Cancer Research. 76: 2490-2490. DOI: 10.1158/1538-7445.Am2016-2490 |
0.381 |
|
| 2016 |
Kaushik G, Seshacharyulu P, Rachagani S, Macha MA, Ponnusamy MP, Batra SK. Abstract 1726: Targeting pancreatic cancer stem cells by afatinib in organoid culture Cancer Research. 76: 1726-1726. DOI: 10.1158/1538-7445.Am2016-1726 |
0.461 |
|
| 2016 |
Saxena S, Purohit A, Varney M, Batra SK, Singh RK. Abstract 1683: Dual role of semaphorin5A in maintaining epithelial and mesenchymal phenotype in metastatic pancreatic cancer Cancer Research. 76: 1683-1683. DOI: 10.1158/1538-7445.Am2016-1683 |
0.465 |
|
| 2016 |
Ouellette MM, Batra SK, Yan Y. Abstract 1669: Inhibition of the Rac1/PAK pathway sensitizes pancreatic cancer cells to gamma-irradiation Cancer Research. 76: 1669-1669. DOI: 10.1158/1538-7445.Am2016-1669 |
0.471 |
|
| 2016 |
Muniyan S, Haridas D, Rachagani S, Lakshmanan I, Gupta S, Chugh S, Seshacharyulu P, Ponnusamy MP, Batra SK. Abstract 1629: Novel interaction of MUC16 with FAK activate EMT process and metastasis of pancreatic ductal adenocarcinoma Cancer Research. 76: 1629-1629. DOI: 10.1158/1538-7445.Am2016-1629 |
0.466 |
|
| 2015 |
Krishn SR, Batra SK, Kaur S. Advances in miRNA-Mediated Mucin Regulation. Current Pharmacology Reports. 1: 355-364. PMID 27867838 DOI: 10.1007/S40495-014-0010-X |
0.305 |
|
| 2015 |
Das A, Durrant D, Mitchell C, Dent P, Batra SK, Kukreja RC. Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95. Oncotarget. PMID 26716643 DOI: 10.18632/Oncotarget.6749 |
0.386 |
|
| 2015 |
Vaz AP, Deb S, Rachagani S, Dey P, Muniyan S, Lakshmanan I, Karmakar S, Smith L, Johansson S, Lele S, Ouellette M, Ponnusamy MP, Batra SK. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. Oncotarget. PMID 26689992 DOI: 10.18632/Oncotarget.6580 |
0.653 |
|
| 2015 |
Kaur S, Krishn SR, Rachagani S, Batra SK. Significance of microRNA-based biomarkers for pancreatic cancer. Annals of Translational Medicine. 3: 277. PMID 26605323 DOI: 10.3978/J.Issn.2305-5839.2015.10.32 |
0.398 |
|
| 2015 |
Dutta S, Roy S, Polavaram NS, Stanton MJ, Zhang H, Bhola T, Hönscheid P, Donohue TM, Band H, Batra SK, Muders MH, Datta K. Neuropilin-2 regulates endosome maturation and EGFR trafficking to support cancer cell pathobiology. Cancer Research. PMID 26560516 DOI: 10.1158/0008-5472.Can-15-1488 |
0.466 |
|
| 2015 |
Das S, Batra SK. Understanding the Unique Attributes of MUC16 (CA125): Potential Implications in Targeted Therapy. Cancer Research. PMID 26527287 DOI: 10.1158/0008-5472.Can-15-1050 |
0.391 |
|
| 2015 |
Pai P, Rachagani S, Lakshmanan I, Macha MA, Sheinin Y, Smith LM, Ponnusamy MP, Batra SK. The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. Molecular Oncology. PMID 26526617 DOI: 10.1016/J.Molonc.2015.10.005 |
0.347 |
|
| 2015 |
Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, ... ... Batra SK, et al. Tumour exosome integrins determine organotropic metastasis. Nature. PMID 26524530 DOI: 10.1038/Nature15756 |
0.362 |
|
| 2015 |
Rachagani S, Macha MA, Menning MS, Dey P, Pai P, Smith LM, Mo YY, Batra SK. Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model. Oncotarget. PMID 26516699 DOI: 10.18632/Oncotarget.5641 |
0.486 |
|
| 2015 |
Das S, Rachagani S, Sheinin Y, Smith LM, Gurumurthy CB, Roy HK, Batra SK. Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer. Oncogene. PMID 26364605 DOI: 10.1038/Onc.2015.327 |
0.357 |
|
| 2015 |
Chugh S, Gnanapragassam VS, Jain M, Rachagani S, Ponnusamy MP, Batra SK. Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets. Biochimica Et Biophysica Acta. 1856: 211-225. PMID 26318196 DOI: 10.1016/J.Bbcan.2015.08.003 |
0.418 |
|
| 2015 |
Muniyan S, Chen SJ, Lin FF, Wang Z, Mehta PP, Batra SK, Lin MF. ErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cells. Cellular Signalling. PMID 26257301 DOI: 10.1016/J.Cellsig.2015.08.002 |
0.402 |
|
| 2015 |
Ingersoll MA, Lyons AS, Muniyan S, D'Cunha N, Robinson T, Hoelting K, Dwyer JG, Bu XR, Batra SK, Lin MF. Novel Imidazopyridine Derivatives Possess Anti-Tumor Effect on Human Castration-Resistant Prostate Cancer Cells. Plos One. 10: e0131811. PMID 26121643 DOI: 10.1371/Journal.Pone.0131811 |
0.379 |
|
| 2015 |
Shukla SK, Gunda V, Abrego J, Haridas D, Mishra A, Souchek J, Chaika NV, Yu F, Sasson AR, Lazenby AJ, Batra SK, Singh PK. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. Oncotarget. PMID 26046375 DOI: 10.18632/Oncotarget.4078 |
0.795 |
|
| 2015 |
Das S, Majhi PD, Al-Mugotir MH, Rachagani S, Sorgen P, Batra SK. Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi/post-Golgi compartments. Scientific Reports. 5: 9759. PMID 26044153 DOI: 10.1038/Srep09759 |
0.372 |
|
| 2015 |
Lakshmanan I, Seshacharyulu P, Haridas D, Rachagani S, Gupta S, Joshi S, Guda C, Yan Y, Jain M, Ganti AK, Ponnusamy MP, Batra SK. Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. Oncotarget. PMID 26035354 DOI: 10.18632/Oncotarget.3912 |
0.458 |
|
| 2015 |
Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, Xiang J, Zhang T, Theilen TM, García-Santos G, Williams C, ... ... Batra SK, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nature Cell Biology. 17: 816-26. PMID 25985394 DOI: 10.1038/Ncb3169 |
0.345 |
|
| 2015 |
Chari ST, Kelly K, Hollingsworth MA, Thayer SP, Ahlquist DA, Andersen DK, Batra SK, Brentnall TA, Canto M, Cleeter DF, Firpo MA, Gambhir SS, Go VL, Hines OJ, Kenner BJ, et al. Early Detection of Sporadic Pancreatic Cancer: Summative Review. Pancreas. 44: 693-712. PMID 25931254 DOI: 10.1097/Mpa.0000000000000368 |
0.374 |
|
| 2015 |
Higashi M, Yokoyama S, Yamamoto T, Goto Y, Kitazono I, Hiraki T, Taguchi H, Hashimoto S, Fukukura Y, Koriyama C, Mataki Y, Maemura K, Shinchi H, Jain M, Batra SK, et al. Mucin Expression in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Specimens Is a Useful Prognostic Factor in Pancreatic Ductal Adenocarcinoma. Pancreas. 44: 728-34. PMID 25906442 DOI: 10.1097/Mpa.0000000000000362 |
0.353 |
|
| 2015 |
Jain S, Suklabaidya S, Das B, Raghav SK, Batra SK, Senapati S. TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells. The Prostate. 75: 1020-33. PMID 25833062 DOI: 10.1002/Pros.22983 |
0.41 |
|
| 2015 |
Das S, Rachagani S, Torres-Gonzalez MP, Lakshmanan I, Majhi PD, Smith LM, Wagner KU, Batra SK. Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells. Oncotarget. 6: 5772-87. PMID 25691062 DOI: 10.18632/Oncotarget.3308 |
0.458 |
|
| 2015 |
Seshacharyulu P, Ponnusamy MP, Rachagani S, Lakshmanan I, Haridas D, Yan Y, Ganti AK, Batra SK. Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer. Oncotarget. 6: 5164-81. PMID 25686822 DOI: 10.18632/Oncotarget.3286 |
0.483 |
|
| 2015 |
Mimeault M, Rachagani S, Muniyan S, Seshacharyulu P, Johansson SL, Datta K, Lin MF, Batra SK. Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer. Oncotarget. 6: 3887-903. PMID 25682877 DOI: 10.18632/Oncotarget.2932 |
0.395 |
|
| 2015 |
Kumar V, Mondal G, Slavik P, Rachagani S, Batra SK, Mahato RI. Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer. Molecular Pharmaceutics. 12: 1289-98. PMID 25679326 DOI: 10.1021/Mp500847S |
0.353 |
|
| 2015 |
Joshi S, Kumar S, Bafna S, Rachagani S, Wagner KU, Jain M, Batra SK. Genetically engineered mucin mouse models for inflammation and cancer. Cancer Metastasis Reviews. PMID 25634251 DOI: 10.1007/S10555-015-9549-1 |
0.682 |
|
| 2015 |
Macha MA, Krishn SR, Jahan R, Banerjee K, Batra SK, Jain M. Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer. Cancer Treatment Reviews. 41: 277-88. PMID 25624117 DOI: 10.1016/J.Ctrv.2015.01.001 |
0.366 |
|
| 2015 |
Pandey P, Rachagani S, Das S, Seshacharyulu P, Sheinin Y, Naslavsky N, Pan Z, Smith BL, Peters HL, Radhakrishnan P, McKenna NR, Giridharan SS, Haridas D, Kaur S, Hollingsworth MA, ... ... Batra SK, et al. Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis. Oncotarget. 6: 2064-75. PMID 25576918 DOI: 10.18632/Oncotarget.2990 |
0.475 |
|
| 2015 |
Das S, Batra SK. Pancreatic cancer metastasis: are we being pre-EMTed? Current Pharmaceutical Design. 21: 1249-55. PMID 25506899 DOI: 10.2174/1381612821666141211115234 |
0.463 |
|
| 2015 |
Rachagani S, Macha MA, Heimann N, Seshacharyulu P, Haridas D, Chugh S, Batra SK. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. Advanced Drug Delivery Reviews. 81: 16-33. PMID 25453266 DOI: 10.1016/J.Addr.2014.10.020 |
0.406 |
|
| 2015 |
Lakshmanan I, Ponnusamy MP, Macha MA, Haridas D, Majhi PD, Kaur S, Jain M, Batra SK, Ganti AK. Mucins in lung cancer: diagnostic, prognostic, and therapeutic implications. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 19-27. PMID 25319180 DOI: 10.1097/Jto.0000000000000404 |
0.427 |
|
| 2015 |
Krasnoslobodtsev AV, Torres MP, Kaur S, Vlassiouk IV, Lipert RJ, Jain M, Batra SK, Lyubchenko YL. Nano-immunoassay with improved performance for detection of cancer biomarkers. Nanomedicine : Nanotechnology, Biology, and Medicine. 11: 167-73. PMID 25200613 DOI: 10.1016/J.Nano.2014.08.012 |
0.322 |
|
| 2015 |
Kamikawa Y, Kanmura Y, Hamada T, Yamada N, Macha MA, Batra SK, Higashi M, Yonezawa S, Sugihara K. Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma. International Journal of Clinical Oncology. 20: 298-307. PMID 24909613 DOI: 10.1007/S10147-014-0710-6 |
0.372 |
|
| 2015 |
Yan Y, Hein AL, Greer PM, Wang Z, Kolb RH, Batra SK, Cowan KH. A novel function of HER2/Neu in the activation of G2/M checkpoint in response to γ-irradiation. Oncogene. 34: 2215-26. PMID 24909175 DOI: 10.1038/Onc.2014.167 |
0.353 |
|
| 2015 |
Kumar S, Torres MP, Kaur S, Rachagani S, Joshi S, Johansson SL, Momi N, Baine MJ, Gilling CE, Smith LM, Wyatt TA, Jain M, Joshi SS, Batra SK. Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages. Oncogene. 34: 2052-60. PMID 24909166 DOI: 10.1038/Onc.2014.154 |
0.779 |
|
| 2015 |
Macha MA, Rachagani S, Pai P, Gupta S, Lydiatt WM, Smith RB, Johansson SL, Lele SM, Kakar SS, Farghaly H, Lee JH, Meza J, Ganti AK, Jain M, Batra SK. MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway. Oncogene. 34: 1698-708. PMID 24747969 DOI: 10.1038/Onc.2014.102 |
0.422 |
|
| 2015 |
Chugh S, Gnanapragassam VS, Jain M, Ponnusamy M, Batra SK. Abstract 4983: GALNT3 mediated differential MUC4 glycosylation in the progression of pancreatic cancer Cancer Research. 75: 4983-4983. DOI: 10.1158/1538-7445.Am2015-4983 |
0.458 |
|
| 2015 |
Purohit A, Varney M, Rachagani S, Myneni P, Ouellette M, Batra SK, Singh RK. Abstract 3178: Targeting CXCR2 signaling inhibitsKRAS(G12D)induced autocrine growth transformation by suppressing ERK activation in pancreatic cancer Cancer Research. 75: 3178-3178. DOI: 10.1158/1538-7445.Am2015-3178 |
0.44 |
|
| 2015 |
Joshi S, Kumar S, Ponnusamy MP, Batra SK. Abstract 1256: MUC4 is negatively regulated by hypoxia in ROS-dependent manner in pancreatic cancer Cancer Research. 75: 1256-1256. DOI: 10.1158/1538-7445.Am2015-1256 |
0.481 |
|
| 2015 |
Das S, Batra SK. Pancreatic cancer metastasis: Are we being pre-EMTed? Current Pharmaceutical Design. 21: 1249-1255. |
0.328 |
|
| 2014 |
Vaz AP, Ponnusamy MP, Seshacharyulu P, Batra SK. A concise review on the current understanding of pancreatic cancer stem cells. Journal of Cancer Stem Cell Research. 2. PMID 26451384 |
0.333 |
|
| 2014 |
Shibahara H, Higashi M, Yokoyama S, Rousseau K, Kitazono I, Osako M, Shirahama H, Tashiro Y, Kurumiya Y, Narita M, Kuze S, Hasagawa H, Kato T, Kubota H, Suzuki H, ... ... Batra SK, et al. A comprehensive expression analysis of mucins in appendiceal carcinoma in a multicenter study: MUC3 is a novel prognostic factor. Plos One. 9: e115613. PMID 25551773 DOI: 10.1371/Journal.Pone.0115613 |
0.31 |
|
| 2014 |
Kumar S, Das S, Rachagani S, Kaur S, Joshi S, Johansson SL, Ponnusamy MP, Jain M, Batra SK. NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer. Oncogene. PMID 25531332 DOI: 10.1038/Onc.2014.409 |
0.436 |
|
| 2014 |
Yan Y, Hein AL, Etekpo A, Burchett KM, Lin C, Enke CA, Batra SK, Cowan KH, Ouellette MM. Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. Oncotarget. 5: 10251-70. PMID 25344910 DOI: 10.18632/Oncotarget.2500 |
0.474 |
|
| 2014 |
Ponnusamy MP, Batra SK. Insights into the role of nicotine in pancreatic stem cell activation and acinar dedifferentiation. Gastroenterology. 147: 962-5. PMID 25265575 DOI: 10.1053/J.Gastro.2014.09.026 |
0.325 |
|
| 2014 |
Kakar SS, Ratajczak MZ, Powell KS, Moghadamfalahi M, Miller DM, Batra SK, Singh SK. Withaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells. Plos One. 9: e107596. PMID 25264898 DOI: 10.1371/Journal.Pone.0107596 |
0.433 |
|
| 2014 |
Joshi S, Kumar S, Choudhury A, Ponnusamy MP, Batra SK. Altered Mucins (MUC) trafficking in benign and malignant conditions. Oncotarget. 5: 7272-84. PMID 25261375 DOI: 10.18632/Oncotarget.2370 |
0.428 |
|
| 2014 |
Souchek JJ, Baine MJ, Lin C, Rachagani S, Gupta S, Kaur S, Lester K, Zheng D, Chen S, Smith L, Lazenby A, Johansson SL, Jain M, Batra SK. Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation. British Journal of Cancer. 111: 1139-49. PMID 25025965 DOI: 10.1038/Bjc.2014.385 |
0.809 |
|
| 2014 |
Vaz AP, Ponnusamy MP, Rachagani S, Dey P, Ganti AK, Batra SK. Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells British Journal of Cancer. 111: 486-496. PMID 25003666 DOI: 10.1038/Bjc.2014.152 |
0.586 |
|
| 2014 |
Haridas D, Ponnusamy MP, Chugh S, Lakshmanan I, Seshacharyulu P, Batra SK. MUC16: Molecular analysis and its functional implications in benign and malignant conditions Faseb Journal. 28: 4183-4199. PMID 25002120 DOI: 10.1096/Fj.14-257352 |
0.402 |
|
| 2014 |
Chakraborty S, Smith L, Ganti AK, Bonthu N, Batra SK. Author's response to "Country of origin and breast cancer survival". Asia-Pacific Journal of Clinical Oncology. 10: 280. PMID 24965198 DOI: 10.1111/Ajco.12212 |
0.301 |
|
| 2014 |
Dey P, Rachagani S, Vaz AP, Ponnusamy MP, Batra SK. PD2/Paf1 depletion in pancreatic acinar cells promotes acinar-to-ductal metaplasia. Oncotarget. 5: 4480-91. PMID 24947474 DOI: 10.18632/Oncotarget.2041 |
0.566 |
|
| 2014 |
Muniyan S, Ingersoll MA, Batra SK, Lin MF. Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor. Biochimica Et Biophysica Acta. 1846: 88-98. PMID 24747769 DOI: 10.1016/J.Bbcan.2014.04.006 |
0.325 |
|
| 2014 |
Shibahara H, Higashi M, Koriyama C, Yokoyama S, Kitazono I, Kurumiya Y, Narita M, Kuze S, Kyokane T, Mita S, Arai T, Kato T, Yuasa N, Yamaguchi R, Kubota H, ... ... Batra SK, et al. Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer. Plos One. 9: e86111. PMID 24722639 DOI: 10.1371/Journal.Pone.0086111 |
0.341 |
|
| 2014 |
Yokoyama S, Kitamoto S, Higashi M, Goto Y, Hara T, Ikebe D, Yamaguchi T, Arisaka Y, Niihara T, Nishimata H, Tanaka S, Takaori K, Batra SK, Yonezawa S. Diagnosis of pancreatic neoplasms using a novel method of DNA methylation analysis of mucin expression in pancreatic juice. Plos One. 9: e93760. PMID 24714692 DOI: 10.1371/Journal.Pone.0093760 |
0.399 |
|
| 2014 |
Kaur S, Momi N, Chakraborty S, Wagner DG, Horn AJ, Lele SM, Theodorescu D, Batra SK. Altered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosis. Plos One. 9: e92742. PMID 24671186 DOI: 10.1371/Journal.Pone.0092742 |
0.714 |
|
| 2014 |
Macha MA, Seshacharyulu P, Krishn SR, Pai P, Rachagani S, Jain M, Batra SK. MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers. Current Pharmaceutical Design. 20: 5287-97. PMID 24479799 DOI: 10.2174/1381612820666140128213117 |
0.397 |
|
| 2014 |
Mimeault M, Batra SK. Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers Cancer Epidemiology Biomarkers and Prevention. 23: 234-254. PMID 24273063 DOI: 10.1158/1055-9965.Epi-13-0785 |
0.481 |
|
| 2014 |
Kaur S, Sharma N, Krishn SR, Lakshmanan I, Rachagani S, Baine MJ, Smith LM, Lele SM, Sasson AR, Guha S, Mallya K, Anderson JM, Hollingsworth MA, Batra SK. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 688-700. PMID 24240113 DOI: 10.1158/1078-0432.Ccr-13-2174 |
0.709 |
|
| 2014 |
Momi N, Kaur S, Rachagani S, Ganti AK, Batra SK. Smoking and microRNA dysregulation: a cancerous combination. Trends in Molecular Medicine. 20: 36-47. PMID 24238736 DOI: 10.1016/J.Molmed.2013.10.005 |
0.696 |
|
| 2014 |
Mimeault M, Batra SK. Introduction at the special issue on implications of cancer stem/progenitor cell concepts in molecular oncology and novel targeted therapies. Molecular Aspects of Medicine. 39: 1-2. PMID 24080440 DOI: 10.1016/J.Mam.2013.09.001 |
0.37 |
|
| 2014 |
Mimeault M, Batra SK. Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies. Molecular Aspects of Medicine. 39: 3-32. PMID 23994756 DOI: 10.1016/J.Mam.2013.08.001 |
0.459 |
|
| 2014 |
Purohit A, Varney M, Rachagani S, Ouellette M, Batra SK, Singh RK. Abstract 4874: CXCR2 signaling axis- a helping hand to KRAS(G12D) mutation in pancreatic cancer initiation Cancer Research. 74: 4874-4874. DOI: 10.1158/1538-7445.Am2014-4874 |
0.463 |
|
| 2013 |
Torres MP, Rachagani S, Souchek JJ, Mallya K, Johansson SL, Batra SK. Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy. Plos One. 8: e80580. PMID 24278292 DOI: 10.1371/Journal.Pone.0080580 |
0.774 |
|
| 2013 |
Radhakrishnan P, Mohr AM, Grandgenett PM, Steele MM, Batra SK, Hollingsworth MA. MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer. Plos One. 8: e73356. PMID 24204560 DOI: 10.1371/Journal.Pone.0073356 |
0.408 |
|
| 2013 |
Ponnusamy MP, Seshacharyulu P, Lakshmanan I, Vaz AP, Chugh S, Batra SK. Emerging role of mucins in epithelial to mesenchymal transition. Current Cancer Drug Targets. 13: 945-56. PMID 24168188 DOI: 10.2174/15680096113136660100 |
0.416 |
|
| 2013 |
Vaz AP, Ponnusamy MP, Batra SK. Cancer stem cells and therapeutic targets: an emerging field for cancer treatment. Drug Delivery and Translational Research. 3: 113-20. PMID 24077517 DOI: 10.1007/S13346-012-0095-X |
0.445 |
|
| 2013 |
Macha MA, Batra SK, Ganti AK. Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma. Cancer Management and Research. 5: 197-203. PMID 23940421 DOI: 10.2147/Cmar.S45976 |
0.329 |
|
| 2013 |
Kitazono I, Higashi M, Kitamoto S, Yokoyama S, Horinouchi M, Osako M, Shimizu T, Tabata M, Batra SK, Goto M, Yonezawa S. Expression of MUC4 mucin is observed mainly in the intestinal type of intraductal papillary mucinous neoplasm of the pancreas. Pancreas. 42: 1120-8. PMID 23921963 DOI: 10.1097/Mpa.0B013E3182965915 |
0.327 |
|
| 2013 |
Macha MA, Rachagani S, Gupta S, Pai P, Ponnusamy MP, Batra SK, Jain M. Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling. Cancer Letters. 341: 166-77. PMID 23920124 DOI: 10.1016/J.Canlet.2013.07.037 |
0.456 |
|
| 2013 |
Kaur S, Kumar S, Momi N, Sasson AR, Batra SK. Mucins in pancreatic cancer and its microenvironment. Nature Reviews. Gastroenterology & Hepatology. 10: 607-20. PMID 23856888 DOI: 10.1038/Nrgastro.2013.120 |
0.76 |
|
| 2013 |
Jain M, Gupta S, Kaur S, Ponnusamy MP, Batra SK. Emerging trends for radioimmunotherapy in solid tumors. Cancer Biotherapy & Radiopharmaceuticals. 28: 639-50. PMID 23844555 DOI: 10.1089/Cbr.2013.1523 |
0.304 |
|
| 2013 |
Pai P, Rachagani S, Are C, Batra SK. Prospects of miRNA-based therapy for pancreatic cancer. Current Drug Targets. 14: 1101-9. PMID 23834151 DOI: 10.2174/13894501113149990181 |
0.313 |
|
| 2013 |
Pandey P, Seshacharyulu P, Das S, Rachagani S, Ponnusamy MP, Yan Y, Johansson SL, Datta K, Fong Lin M, Batra SK. Impaired expression of protein phosphatase 2A subunits enhances metastatic potential of human prostate cancer cells through activation of AKT pathway. British Journal of Cancer. 108: 2590-600. PMID 23598299 DOI: 10.1038/Bjc.2013.160 |
0.366 |
|
| 2013 |
Horn A, Chakraborty S, Dey P, Haridas D, Souchek J, Batra SK, Lele SM. Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology. Archives of Pathology & Laboratory Medicine. 137: 546-51. PMID 23544943 DOI: 10.5858/Arpa.2011-0229-Oa |
0.786 |
|
| 2013 |
Mimeault M, Batra SK. Development of animal models underlining mechanistic connections between prostate inflammation and cancer. World Journal of Clinical Oncology. 4: 4-13. PMID 23539141 DOI: 10.5306/Wjco.V4.I1.4 |
0.319 |
|
| 2013 |
Shimizu T, Torres MP, Chakraborty S, Souchek JJ, Rachagani S, Kaur S, Macha M, Ganti AK, Hauke RJ, Batra SK. Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: potential role in therapy. Cancer Letters. 336: 270-80. PMID 23523869 DOI: 10.1016/J.Canlet.2013.03.017 |
0.772 |
|
| 2013 |
Lin WC, Rajbhandari N, Liu C, Sakamoto K, Zhang Q, Triplett AA, Batra SK, Opavsky R, Felsher DW, DiMaio DJ, Hollingsworth MA, Morris JP, Hebrok M, Witkiewicz AK, Brody JR, et al. Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. Cancer Research. 73: 1821-30. PMID 23467612 DOI: 10.1158/0008-5472.Can-12-2067 |
0.491 |
|
| 2013 |
Seshacharyulu P, Pandey P, Datta K, Batra SK. Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. Cancer Letters. 335: 9-18. PMID 23454242 DOI: 10.1016/J.Canlet.2013.02.036 |
0.396 |
|
| 2013 |
Mimeault M, Johansson SL, Batra SK. Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1. British Journal of Cancer. 108: 1079-91. PMID 23449353 DOI: 10.1038/Bjc.2012.484 |
0.355 |
|
| 2013 |
Mukhopadhyay P, Lakshmanan I, Ponnusamy MP, Chakraborty S, Jain M, Pai P, Smith LM, Lele SM, Batra SK. MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells. Plos One. 8: e54455. PMID 23408941 DOI: 10.1371/Journal.Pone.0054455 |
0.41 |
|
| 2013 |
Kaur S, Chakraborty S, Baine MJ, Mallya K, Smith LM, Sasson A, Brand R, Guha S, Jain M, Wittel U, Singh SK, Batra SK. Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer. Plos One. 8: e55171. PMID 23383312 DOI: 10.1371/Journal.Pone.0055171 |
0.656 |
|
| 2013 |
Majhi PD, Lakshmanan I, Ponnusamy MP, Jain M, Das S, Kaur S, Shimizu ST, West WW, Johansson SL, Smith LM, Yu F, Rolle CE, Sharma P, Carey GB, Batra SK, et al. Pathobiological implications of MUC4 in non-small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 398-407. PMID 23370366 DOI: 10.1097/Jto.0B013E3182829E06 |
0.438 |
|
| 2013 |
Gnanapragassam VS, Jain M, Batra SK. Analysis of tumor-associated mucin glycotopes by Western transfer methods. Methods in Molecular Biology (Clifton, N.J.). 980: 331-40. PMID 23359164 DOI: 10.1007/978-1-62703-287-2_19 |
0.372 |
|
| 2013 |
Baine MJ, Mallya K, Batra SK. Quantitative real-time PCR expression analysis of peripheral blood mononuclear cells in pancreatic cancer patients. Methods in Molecular Biology (Clifton, N.J.). 980: 157-73. PMID 23359153 DOI: 10.1007/978-1-62703-287-2_8 |
0.675 |
|
| 2013 |
Kaur S, Shimizu T, Baine MJ, Kumar S, Batra SK. Immunohistochemistry of pancreatic neoplasia. Methods in Molecular Biology (Clifton, N.J.). 980: 29-42. PMID 23359148 DOI: 10.1007/978-1-62703-287-2_3 |
0.678 |
|
| 2013 |
Mimeault M, Batra SK. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells. Journal of Cellular and Molecular Medicine. 17: 30-54. PMID 23301832 DOI: 10.1111/Jcmm.12004 |
0.433 |
|
| 2013 |
Kaur S, Baine MJ, Guha S, Ochi N, Chakraborty S, Mallya K, Thomas C, Crook J, Wallace MB, Woodward TA, Jain M, Singh S, Sasson AR, Skinner V, Raimondo M, ... Batra SK, et al. Neutrophil gelatinase-associated lipocalin, macrophage inhibitory cytokine 1, and carbohydrate antigen 19-9 in pancreatic juice: pathobiologic implications in diagnosing benign and malignant disease of the pancreas. Pancreas. 42: 494-501. PMID 23146921 DOI: 10.1097/Mpa.0B013E31826A8597 |
0.657 |
|
| 2013 |
Mimeault M, Batra SK. Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials. Drug Discovery Today. 18: 128-40. PMID 22903142 DOI: 10.1016/J.Drudis.2012.08.002 |
0.392 |
|
| 2013 |
Momi N, Ponnusamy MP, Kaur S, Rachagani S, Kunigal SS, Chellappan S, Ouellette MM, Batra SK. Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation. Oncogene. 32: 1384-95. PMID 22614008 DOI: 10.1038/Onc.2012.163 |
0.721 |
|
| 2013 |
Chakraborty S, Tarantolo SR, Batra SK, Hauke RJ. Incidence and prognostic significance of second primary cancers in renal cell carcinoma. American Journal of Clinical Oncology. 36: 132-42. PMID 22441339 DOI: 10.1097/Coc.0B013E3182438Ddf |
0.36 |
|
| 2013 |
Das S, Torres-Gonzalez MP, Majhi PD, Lakshmanan I, Ponnusamy MP, Rachagani S, Cruz E, Haridas D, Batra SK. Abstract 5113: Carboxyl terminal region of MUC16 is critical for tumor cell invasion and drug resistance. Cancer Research. 73: 5113-5113. DOI: 10.1158/1538-7445.Am2013-5113 |
0.417 |
|
| 2013 |
Vaz AP, Ponnusamy MP, Rachagani S, Dey P, Batra S. Abstract 271: Overexpression of hPaf1/PD2 in pancreatic cancer stem cells results in stemness and drug resistance: a novel target for pancreatic cancer therapy. Cancer Research. 73: 271-271. DOI: 10.1158/1538-7445.Am2013-271 |
0.593 |
|
| 2013 |
Lakshmanan I, Majhi PD, Ponnusamy MP, Das S, Seshacharyulu P, Haridas D, Batra SK, Ganti A. Abstract 1760: MUC16 upregulates TSPYL5 gene and mediates Lung cancer cell proliferation by suppressing p53 activity. Cancer Research. 73: 1760-1760. DOI: 10.1158/1538-7445.Am2013-1760 |
0.429 |
|
| 2013 |
Haridas D, Lakshmanan I, Ponnusamy MP, Rachagani S, Das S, Kumar S, Batra SK. Abstract 1745: Role and mechanism of MUC16 in the pathogenesis of pancreatic cancer. Cancer Research. 73: 1745-1745. DOI: 10.1158/1538-7445.Am2013-1745 |
0.489 |
|
| 2013 |
Purohit A, Varney M, Rachagani S, Ouellete M, Batra SK, Singh RK. Abstract 1431: Upregulation of CXCR2 and its ligands in KRAS oncogene-induced initiation of pancreatic cancer. Cancer Research. 73: 1431-1431. DOI: 10.1158/1538-7445.Am2013-1431 |
0.459 |
|
| 2013 |
Souchek J, Chakraborty S, Rachagani S, Hauke R, Batra S. Glucocorticoids augment resistance to gemcitabine in pancreatic cancer cells Pancreatology. 13: e75. DOI: 10.1016/J.Pan.2012.12.316 |
0.783 |
|
| 2013 |
Seshacharyulu P, Ponnusamy M, Lakshmanan I, Batra S. Pan-ErbB inhibitor CI 1033 on pancreatic cancer therapy Pancreatology. 13: e72-e73. DOI: 10.1016/J.Pan.2012.12.308 |
0.365 |
|
| 2013 |
Kaur S, Bafna S, Rachagani S, Ganti A, Batra S. Mucin MUC4 resists gemcitabine-induced pancreatic cancer cell death by promoting autophagy Pancreatology. 13: e43. DOI: 10.1016/J.Pan.2012.12.204 |
0.684 |
|
| 2013 |
Joshi S, Kumar S, Batra S. MUC4 is a novel regulator of EGFR trafficking in pancreatic cancer Pancreatology. 13: e41. DOI: 10.1016/J.Pan.2012.12.197 |
0.424 |
|
| 2012 |
Momi N, Kaur S, Krishn SR, Batra SK. Discovering the route from inflammation to pancreatic cancer. Minerva Gastroenterologica E Dietologica. 58: 283-97. PMID 23207606 |
0.7 |
|
| 2012 |
Tamura Y, Higashi M, Kitamoto S, Yokoyama S, Osako M, Horinouchi M, Shimizu T, Tabata M, Batra SK, Goto M, Yonezawa S. MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer. Plos One. 7: e49251. PMID 23152882 DOI: 10.1371/Journal.Pone.0049251 |
0.36 |
|
| 2012 |
Rachagani S, Torres MP, Kumar S, Haridas D, Baine M, Macha MA, Kaur S, Ponnusamy MP, Dey P, Seshacharyulu P, Johansson SL, Jain M, Wagner KU, Batra SK. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy. Journal of Hematology & Oncology. 5: 68. PMID 23102107 DOI: 10.1186/1756-8722-5-68 |
0.756 |
|
| 2012 |
Kaur S, Baine MJ, Jain M, Sasson AR, Batra SK. Early diagnosis of pancreatic cancer: challenges and new developments. Biomarkers in Medicine. 6: 597-612. PMID 23075238 DOI: 10.2217/Bmm.12.69 |
0.698 |
|
| 2012 |
Dey P, Rachagani S, Chakraborty S, Singh PK, Zhao X, Gurumurthy CB, Anderson JM, Lele S, Hollingsworth MA, Band V, Batra SK. Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 6188-98. PMID 22977192 DOI: 10.1158/1078-0432.Ccr-12-1789 |
0.668 |
|
| 2012 |
Kitamoto S, Yokoyama S, Higashi M, Yamada N, Matsubara S, Takao S, Batra SK, Yonezawa S. Expression of MUC17 is regulated by HIF1α-mediated hypoxic responses and requires a methylation-free hypoxia responsible element in pancreatic cancer. Plos One. 7: e44108. PMID 22970168 DOI: 10.1371/Journal.Pone.0044108 |
0.466 |
|
| 2012 |
Rachagani S, Macha MA, Ponnusamy MP, Haridas D, Kaur S, Jain M, Batra SK. MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1. Carcinogenesis. 33: 1953-64. PMID 22791819 DOI: 10.1093/Carcin/Bgs225 |
0.472 |
|
| 2012 |
Sadanandam A, Sidhu SS, Wullschleger S, Singh S, Varney ML, Yang CS, Ashour AE, Batra SK, Singh RK. Secreted semaphorin 5A suppressed pancreatic tumour burden but increased metastasis and endothelial cell proliferation. British Journal of Cancer. 107: 501-7. PMID 22782341 DOI: 10.1038/Bjc.2012.298 |
0.44 |
|
| 2012 |
Chen AC, Migliaccio I, Rimawi M, Lopez-Tarruella S, Creighton CJ, Massarweh S, Huang C, Wang YC, Batra SK, Gutierrez MC, Osborne CK, Schiff R. Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies. Breast Cancer Research and Treatment. 134: 583-93. PMID 22644656 DOI: 10.1007/S10549-012-2082-9 |
0.35 |
|
| 2012 |
Momi N, Kaur S, Ponnusamy MP, Kumar S, Wittel UA, Batra SK. Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis. Carcinogenesis. 33: 1617-28. PMID 22623649 DOI: 10.1093/Carcin/Bgs186 |
0.698 |
|
| 2012 |
Kunigal S, Ponnusamy MP, Momi N, Batra SK, Chellappan SP. Nicotine, IFN-γ and retinoic acid mediated induction of MUC4 in pancreatic cancer requires E2F1 and STAT-1 transcription factors and utilize different signaling cascades. Molecular Cancer. 11: 24. PMID 22537161 DOI: 10.1186/1476-4598-11-24 |
0.759 |
|
| 2012 |
Kelsey L, Katoch P, Johnson KE, Batra SK, Mehta PP. Retinoids regulate the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. Plos One. 7: e32846. PMID 22514600 DOI: 10.1371/Journal.Pone.0032846 |
0.346 |
|
| 2012 |
Chakraborty S, Kaur S, Guha S, Batra SK. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochimica Et Biophysica Acta. 1826: 129-69. PMID 22513004 DOI: 10.1016/J.Bbcan.2012.03.008 |
0.43 |
|
| 2012 |
Torres MP, Rachagani S, Purohit V, Pandey P, Joshi S, Moore ED, Johansson SL, Singh PK, Ganti AK, Batra SK. Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism. Cancer Letters. 323: 29-40. PMID 22475682 DOI: 10.1016/J.Canlet.2012.03.031 |
0.46 |
|
| 2012 |
Mimeault M, Batra SK. Great promise of tissue-resident adult stem/progenitor cells in transplantation and cancer therapies. Advances in Experimental Medicine and Biology. 741: 171-86. PMID 22457110 DOI: 10.1007/978-1-4614-2098-9_12 |
0.343 |
|
| 2012 |
Wittel UA, Momi N, Seifert G, Wiech T, Hopt UT, Batra SK. The pathobiological impact of cigarette smoke on pancreatic cancer development (review). International Journal of Oncology. 41: 5-14. PMID 22446714 DOI: 10.3892/Ijo.2012.1414 |
0.708 |
|
| 2012 |
Mimeault M, Batra SK. Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas. World Journal of Clinical Oncology. 3: 32-42. PMID 22442756 DOI: 10.5306/Wjco.V3.I3.32 |
0.382 |
|
| 2012 |
Hamada T, Nomura M, Kamikawa Y, Yamada N, Batra SK, Yonezawa S, Sugihara K. DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma. Cancer. 118: 5251-64. PMID 22434549 DOI: 10.1002/Cncr.27542 |
0.363 |
|
| 2012 |
Mimeault M, Johansson SL, Batra SK. Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progenies. Plos One. 7: e31919. PMID 22384099 DOI: 10.1371/Journal.Pone.0031919 |
0.413 |
|
| 2012 |
Torres MP, Chakraborty S, Souchek J, Batra SK. Mucin-based targeted pancreatic cancer therapy. Current Pharmaceutical Design. 18: 2472-81. PMID 22372499 DOI: 10.2174/13816128112092472 |
0.787 |
|
| 2012 |
Tarang S, Kumar S, Batra SK. Mucins and toll-like receptors: kith and kin in infection and cancer. Cancer Letters. 321: 110-9. PMID 22306702 DOI: 10.1016/J.Canlet.2012.01.040 |
0.391 |
|
| 2012 |
Higashi M, Yamada N, Yokoyama S, Kitamoto S, Tabata K, Koriyama C, Batra SK, Yonezawa S. Pathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology. 79: 101-6. PMID 22286058 DOI: 10.1159/000335164 |
0.334 |
|
| 2012 |
Seshacharyulu P, Ponnusamy MP, Haridas D, Jain M, Ganti AK, Batra SK. Targeting the EGFR signaling pathway in cancer therapy. Expert Opinion On Therapeutic Targets. 16: 15-31. PMID 22239438 DOI: 10.1517/14728222.2011.648617 |
0.338 |
|
| 2012 |
Senapati S, Gnanapragassam VS, Moniaux N, Momi N, Batra SK. Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells. Oncogene. 31: 3346-56. PMID 22105367 DOI: 10.1038/Onc.2011.505 |
0.732 |
|
| 2012 |
Hamada T, Wakamatsu T, Miyahara M, Nagata S, Nomura M, Kamikawa Y, Yamada N, Batra SK, Yonezawa S, Sugihara K. MUC4: a novel prognostic factor of oral squamous cell carcinoma. International Journal of Cancer. Journal International Du Cancer. 130: 1768-76. PMID 21618516 DOI: 10.1002/Ijc.26187 |
0.358 |
|
| 2012 |
Senapati S, Batra S, Chakraborty S, Nath I, Panda S, Patra R. Non-human prostate cancer cell lines Oncology, Gastroenterology and Hepatology Reports. 1: 15. DOI: 10.4103/2348-3113.133625 |
0.377 |
|
| 2012 |
Ganti AK, Kaur S, West WW, Dhangada Majhi P, Lakshmanan I, Smith L, Rolle CE, Carey G, Sharma P, Salgia R, Batra S. MUC4 expression in non-small cell lung cancer. Journal of Clinical Oncology. 30: e17549-e17549. DOI: 10.1200/Jco.2012.30.15_Suppl.E17549 |
0.341 |
|
| 2012 |
Lin W, Rajbhandari N, Liu C, Sakamoto K, Batra S, Opavsky R, Felsher D, Hollingsworth M, Hebrok M, Rui H, Wagner K. Abstract LB-429: Dormant cancer cells contribute to residual disease in a mouse model for reversible pancreatic cancer Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-429 |
0.487 |
|
| 2012 |
Baine M, Lester K, Lin C, Chen S, Kaur S, Sahak F, Batra SK. Unbiased Analysis of Pancreatic Cancer Radiation Resistance Reveals Cholesterol Biosynthesis as a Potent Novel Target for Radiosensitization International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.430 |
0.664 |
|
| 2012 |
Sadanandam A, Varney ML, Singh S, Ashour AE, Moniaux N, Deb S, Lele SM, Batra SK, Singh RK. Erratum: High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis (International Journal of Cancer (2010) 127 (1373-1383) DOI: 10.1002/ijc.25166) International Journal of Cancer. 130. DOI: 10.1002/Ijc.27492 |
0.608 |
|
| 2011 |
Hauke RJ, Tarantolo SR, Batra S, Chakraborty S. Second primary cancers and their prognostic significance in patients with renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 377. PMID 27968511 DOI: 10.1200/Jco.2011.29.7_Suppl.377 |
0.342 |
|
| 2011 |
Tong Z, Chakraborty S, Sung B, Koolwal P, Kaur S, Aggarwal BB, Mani SA, Bresalier RS, Batra SK, Guha S. Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells. Cancer. 117: 2408-18. PMID 24048788 DOI: 10.1002/Cncr.25803 |
0.382 |
|
| 2011 |
Baine MJ, Menning M, Smith LM, Mallya K, Kaur S, Rachagani S, Chakraborty S, Sasson AR, Brand RE, Batra SK. Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer. Cancer Biomarkers : Section a of Disease Markers. 11: 1-14. PMID 22820136 DOI: 10.3233/Cbm-2012-0260 |
0.676 |
|
| 2011 |
Haridas D, Chakraborty S, Ponnusamy MP, Lakshmanan I, Rachagani S, Cruz E, Kumar S, Das S, Lele SM, Anderson JM, Wittel UA, Hollingsworth MA, Batra SK. Pathobiological implications of MUC16 expression in pancreatic cancer. Plos One. 6: e26839. PMID 22066010 DOI: 10.1371/Journal.Pone.0026839 |
0.464 |
|
| 2011 |
Dey P, Ponnusamy MP, Deb S, Batra SK. Human RNA polymerase II-association factor 1 (hPaf1/PD2) regulates histone methylation and chromatin remodeling in pancreatic cancer. Plos One. 6: e26926. PMID 22046413 DOI: 10.1371/Journal.Pone.0026926 |
0.657 |
|
| 2011 |
Jain M, Venkatraman G, Moniaux N, Kaur S, Kumar S, Chakraborty S, Varshney GC, Batra SK. Monoclonal antibodies recognizing the non-tandem repeat regions of the human mucin MUC4 in pancreatic cancer. Plos One. 6: e23344. PMID 21886786 DOI: 10.1371/Journal.Pone.0023344 |
0.447 |
|
| 2011 |
Mimeault M, Batra SK. Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Chinese Medicine. 6: 31. PMID 21859497 DOI: 10.1186/1749-8546-6-31 |
0.461 |
|
| 2011 |
Lakshmanan I, Ponnusamy MP, Das S, Chakraborty S, Haridas D, Mukhopadhyay P, Lele SM, Batra SK. MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells. Oncogene. 31: 805-17. PMID 21785467 DOI: 10.1038/Onc.2011.297 |
0.411 |
|
| 2011 |
Baine M, Sahak F, Lin C, Chakraborty S, Lyden E, Batra SK. Marital status and survival in pancreatic cancer patients: a SEER based analysis. Plos One. 6: e21052. PMID 21698253 DOI: 10.1371/Journal.Pone.0021052 |
0.649 |
|
| 2011 |
Mimeault M, Batra SK. Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies. Brain Pathology (Zurich, Switzerland). 21: 479-500. PMID 21615592 DOI: 10.1111/J.1750-3639.2011.00505.X |
0.339 |
|
| 2011 |
Mimeault M, Batra SK. Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies. Molecular Medicine (Cambridge, Mass.). 17: 949-64. PMID 21607288 DOI: 10.2119/Molmed.2011.00115 |
0.427 |
|
| 2011 |
Ponnusamy MP, Seshacharyulu P, Vaz A, Dey P, Batra SK. MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells. Journal of Ovarian Research. 4: 7. PMID 21521521 DOI: 10.1186/1757-2215-4-7 |
0.631 |
|
| 2011 |
Mimeault M, Batra SK. Animal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stem/progenitor cells. Biochimica Et Biophysica Acta. 1816: 25-37. PMID 21396984 DOI: 10.1016/J.Bbcan.2011.03.001 |
0.403 |
|
| 2011 |
Resta-Lenert S, Das S, Batra SK, Ho SB. Muc17 protects intestinal epithelial cells from enteroinvasive E. coli infection by promoting epithelial barrier integrity. American Journal of Physiology. Gastrointestinal and Liver Physiology. 300: G1144-55. PMID 21393431 DOI: 10.1152/Ajpgi.00138.2010 |
0.358 |
|
| 2011 |
Wang G, Lipert RJ, Jain M, Kaur S, Chakraboty S, Torres MP, Batra SK, Brand RE, Porter MD. Detection of the potential pancreatic cancer marker MUC4 in serum using surface-enhanced Raman scattering. Analytical Chemistry. 83: 2554-61. PMID 21391573 DOI: 10.1021/Ac102829B |
0.408 |
|
| 2011 |
Rachagani S, Senapati S, Chakraborty S, Ponnusamy MP, Kumar S, Smith LM, Jain M, Batra SK. Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin. British Journal of Cancer. 104: 1038-48. PMID 21364589 DOI: 10.1038/Bjc.2011.31 |
0.439 |
|
| 2011 |
Baine MJ, Chakraborty S, Smith LM, Mallya K, Sasson AR, Brand RE, Batra SK. Transcriptional profiling of peripheral blood mononuclear cells in pancreatic cancer patients identifies novel genes with potential diagnostic utility. Plos One. 6: e17014. PMID 21347333 DOI: 10.1371/Journal.Pone.0017014 |
0.683 |
|
| 2011 |
Mukhopadhyay P, Chakraborty S, Ponnusamy MP, Lakshmanan I, Jain M, Batra SK. Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy. Biochimica Et Biophysica Acta. 1815: 224-40. PMID 21277939 DOI: 10.1016/J.Bbcan.2011.01.001 |
0.386 |
|
| 2011 |
Chakraborty S, Bonthu N, Swanson BJ, Batra SK. Role of mucins in the skin during benign and malignant conditions. Cancer Letters. 301: 127-41. PMID 21146919 DOI: 10.1016/J.Canlet.2010.11.004 |
0.333 |
|
| 2011 |
Senapati S, Chaturvedi P, Chaney WG, Chakraborty S, Gnanapragassam VS, Sasson AR, Batra SK. Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 267-74. PMID 21059814 DOI: 10.1158/1078-0432.Ccr-10-1937 |
0.638 |
|
| 2011 |
Kitamoto S, Yamada N, Yokoyama S, Houjou I, Higashi M, Goto M, Batra SK, Yonezawa S. DNA methylation and histone H3-K9 modifications contribute to MUC17 expression. Glycobiology. 21: 247-56. PMID 20926598 DOI: 10.1093/Glycob/Cwq155 |
0.33 |
|
| 2011 |
Chakraborty S, Baine MJ, Sasson AR, Batra SK. Current status of molecular markers for early detection of sporadic pancreatic cancer. Biochimica Et Biophysica Acta. 1815: 44-64. PMID 20888394 DOI: 10.1016/J.Bbcan.2010.09.002 |
0.654 |
|
| 2011 |
Deb S, Ponnusamy MP, Batra SK. PAF1 (Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae)) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/44536 |
0.466 |
|
| 2011 |
Moniaux N, Chaturvedi P, Van SI, Porchet N, Singh A, Batra S. MUC4 (mucin 4, cell surface associated) Atlas of Genetics and Cytogenetics in Oncology and Haematology. DOI: 10.4267/2042/38441 |
0.548 |
|
| 2011 |
Kitamoto S, Yamada N, Yokoyama S, Houjou I, Higashi M, Goto M, Batra SK, Yonezawa S. Abstract 82: Expression of MUC17, a marker of pancreatic cancer, is under the control of epigenetic modifications Cancer Research. 71: 82-82. DOI: 10.1158/1538-7445.Am2011-82 |
0.362 |
|
| 2011 |
Tong Z, Chakraborty S, Sung B, Kaur S, Aggarwal BB, Mani S, Bresalier RS, Batra S, Guha S. Abstract 5008: Epidermal growth factor downregulates expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells Cancer Research. 71: 5008-5008. DOI: 10.1158/1538-7445.Am2011-5008 |
0.424 |
|
| 2011 |
Lin W, Zhang Q, Opavsky R, DiMaio DJ, Felsher DW, Batra SK, Hollingsworth MA, Wagner K. Abstract 2384: A novel mouse model for the study of c-MYC during initiation and progression of pancreatic ductal adenocarcinoma Cancer Research. 71: 2384-2384. DOI: 10.1158/1538-7445.Am2011-2384 |
0.472 |
|
| 2010 |
Mimeault M, Batra SK. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies. Pharmacological Reviews. 62: 497-524. PMID 20716670 DOI: 10.1124/Pr.109.002329 |
0.411 |
|
| 2010 |
Senapati S, Ho SB, Sharma P, Das S, Chakraborty S, Kaur S, Niehans G, Batra SK. Expression of intestinal MUC17 membrane-bound mucin in inflammatory and neoplastic diseases of the colon. Journal of Clinical Pathology. 63: 702-7. PMID 20702471 DOI: 10.1136/Jcp.2010.078717 |
0.418 |
|
| 2010 |
Ponnusamy MP, Lakshmanan I, Jain M, Das S, Chakraborty S, Dey P, Batra SK. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. Oncogene. 29: 5741-54. PMID 20697346 DOI: 10.1038/Onc.2010.309 |
0.608 |
|
| 2010 |
Chakraborty S, Ganti AK, Marr A, Batra SK. Lung cancer in women: Role of estrogens Expert Review of Respiratory Medicine. 4: 509-518. PMID 20658912 DOI: 10.1586/Ers.10.50 |
0.329 |
|
| 2010 |
Togami S, Nomoto M, Higashi M, Goto M, Yonezawa S, Tsuji T, Batra SK, Douchi T. Expression of mucin antigens (MUC1 and MUC16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix. The Journal of Obstetrics and Gynaecology Research. 36: 588-97. PMID 20598042 DOI: 10.1111/J.1447-0756.2010.01221.X |
0.33 |
|
| 2010 |
Chakraborty S, Swanson BJ, Bonthu N, Batra SK. Aberrant upregulation of MUC4 mucin expression in cutaneous condyloma acuminatum and squamous cell carcinoma suggests a potential role in the diagnosis and therapy of skin diseases. Journal of Clinical Pathology. 63: 579-84. PMID 20591909 DOI: 10.1136/Jcp.2010.076125 |
0.338 |
|
| 2010 |
Murielle M, Batra SK. Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer Journal of Cellular Physiology. 224: 626-635. PMID 20578239 DOI: 10.1002/Jcp.22196 |
0.478 |
|
| 2010 |
Mimeault M, Batra SK. New advances on critical implications of tumorand metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence Histology and Histopathology. 25: 1057-1073. PMID 20552555 DOI: 10.14670/Hh-25.1057 |
0.474 |
|
| 2010 |
Chuang TD, Chen SJ, Lin FF, Veeramani S, Kumar S, Batra SK, Tu Y, Lin MF. Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth. The Journal of Biological Chemistry. 285: 23598-606. PMID 20498373 DOI: 10.1074/Jbc.M109.098301 |
0.378 |
|
| 2010 |
Deng M, Chen PC, Xie S, Zhao J, Gong L, Liu J, Zhang L, Sun S, Liu J, Ma H, Batra SK, Li DW. The small heat shock protein alphaA-crystallin is expressed in pancreas and acts as a negative regulator of carcinogenesis. Biochimica Et Biophysica Acta. 1802: 621-31. PMID 20434541 DOI: 10.1016/J.Bbadis.2010.04.004 |
0.406 |
|
| 2010 |
Torres MP, Ponnusamy MP, Chakraborty S, Smith LM, Das S, Arafat HA, Batra SK. Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: Implications for the development of novel cancer therapies Molecular Cancer Therapeutics. 9: 1419-1431. PMID 20423995 DOI: 10.1158/1535-7163.Mct-10-0075 |
0.511 |
|
| 2010 |
Bafna S, Kaur S, Batra SK. Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene. 29: 2893-904. PMID 20348949 DOI: 10.1038/Onc.2010.87 |
0.708 |
|
| 2010 |
Mimeault M, Batra SK. Recent advancements on the identification of immature cancer cells with the stem cell-like properties in different aggressive and recurrent cancer types Anti-Cancer Agents in Medicinal Chemistry. 10: 103. PMID 20344823 DOI: 10.2174/187152010790909335 |
0.432 |
|
| 2010 |
Mimeault M, Batra SK. New promising drug targets in cancer- and mtastasis-initiating cells Drug Discovery Today. 15: 354-364. PMID 20338259 DOI: 10.1016/J.Drudis.2010.03.009 |
0.451 |
|
| 2010 |
Mimeault M, Johansson SL, Senapati S, Momi N, Chakraborty S, Batra SK. MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies. Cancer Letters. 295: 69-84. PMID 20303649 DOI: 10.1016/J.Canlet.2010.02.015 |
0.739 |
|
| 2010 |
Luu Y, Junker W, Rachagani S, Das S, Batra SK, Heinrikson RL, Shekels LL, Ho SB. Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis International Journal of Biochemistry and Cell Biology. 42: 996-1006. PMID 20211273 DOI: 10.1016/J.Biocel.2010.03.001 |
0.782 |
|
| 2010 |
Mimeault M, Batra SK. Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies Anti-Cancer Agents in Medicinal Chemistry. 10: 137-151. PMID 20184544 DOI: 10.2174/187152010790909353 |
0.469 |
|
| 2010 |
Mimeault M, Johansson SL, Henichart JP, Depreux P, Batra SK. Cytotoxic effects induced by docetaxel, gefitinib, and cyclopamine on side population and nonside population cell fractions from human invasive prostate cancer cells. Molecular Cancer Therapeutics. 9: 617-30. PMID 20179163 DOI: 10.1158/1535-7163.Mct-09-1013 |
0.402 |
|
| 2010 |
Sadanandam A, Varney ML, Singh S, Ashour AE, Moniaux N, Deb S, Lele SM, Batra SK, Singh RK. High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis. International Journal of Cancer. Journal International Du Cancer. 127: 1373-83. PMID 20073063 DOI: 10.1002/Ijc.25166 |
0.645 |
|
| 2010 |
Rachagani S, Kumar S, Batra SK. MicroRNA in pancreatic cancer: Pathological, diagnostic and therapeutic implications Cancer Letters. 292: 8-16. PMID 20004512 DOI: 10.1016/J.Canlet.2009.11.010 |
0.376 |
|
| 2010 |
Senapati S, Rachagani S, Chaudhary K, Johansson SL, Singh RK, Batra SK. Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway. Oncogene. 29: 1293-302. PMID 19946339 DOI: 10.1038/Onc.2009.420 |
0.411 |
|
| 2010 |
Senapati S, Das S, Batra SK. Mucin-interacting proteins: From function to therapeutics Trends in Biochemical Sciences. 35: 236-245. PMID 19913432 DOI: 10.1016/J.Tibs.2009.10.003 |
0.357 |
|
| 2010 |
Mimeault M, Batra SK. Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies Journal of Cellular and Molecular Medicine. 14: 116-134. PMID 19725922 DOI: 10.1111/J.1582-4934.2009.00885.X |
0.351 |
|
| 2010 |
Chakraborty S, Baine M, Kaur S, Mallya K, Jain M, Sasson AR, Batra SK. Abstract LB-212: Elevated plasma NGAL and MIC-1 are novel biomarkers for the diagnosis of pancreatic adenocarcinoma Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-212 |
0.634 |
|
| 2010 |
Torres MP, Ponnusamy MP, Chakraborty S, Arafat HA, Batra SK. Abstract 766: Downregulation of MUC4 in pancreatic cancer cells by thymoquinone: A promise for pancreatic cancer therapies Cancer Research. 70: 766-766. DOI: 10.1158/1538-7445.Am10-766 |
0.524 |
|
| 2010 |
Souchek JJ, Chakraborty S, Rachagani S, Hauke R, Batra SK. Abstract 722: Reciprocal regulation of MUC4 and HER-2 by the corticosteroid fluticasone propionate in pancreatic cancer cells: Potential role in anticancer therapy Cancer Research. 70: 722-722. DOI: 10.1158/1538-7445.Am10-722 |
0.8 |
|
| 2010 |
Ponnusamy MP, Lakshmanan I, Jain M, Batra SK. Abstract 5180: MUC4 mucin upregulates N-cadherin: A novel mechanism for human ovarian tumor metastasis Cancer Research. 70: 5180-5180. DOI: 10.1158/1538-7445.Am10-5180 |
0.315 |
|
| 2010 |
Momi N, Ponnusamy MP, Batra SK. Abstract 431: Cigarette-smoke-induced expression of MUC4 in human pancreatic cancer cells: Potential pathological roles Cancer Research. 70: 431-431. DOI: 10.1158/1538-7445.Am10-431 |
0.73 |
|
| 2010 |
Xiao Y, Gao X, Cheung W, Urbas A, Taratula O, Holbrook D, Cavicchi RE, Souchek JJ, Wagner PD, Srivastava S, Avedisian T, He H, Batra S. Abstract 3686: Antibody-functionalized single-walled carbon nanotubes for detection and selective destruction of breast and pancreas cancer cells Cancer Research. 70: 3686-3686. DOI: 10.1158/1538-7445.Am10-3686 |
0.785 |
|
| 2010 |
Dey P, Chakraborty S, Senapati S, Basavaraju GC, Band V, Batra SK. Abstract 36: Human ecdysoneless protein: Regulator of cholesterol homeostasis in pancreatic cancer Cancer Research. 70: 36-36. DOI: 10.1158/1538-7445.Am10-36 |
0.653 |
|
| 2010 |
Das S, Ponnusamy MP, Johansson SL, Senapati S, Pandey P, Roy HK, Batra SK. Abstract 3075: MUC4 mucin as a potential tumor suppressor in colon cancer Cancer Research. 70: 3075-3075. DOI: 10.1158/1538-7445.Am10-3075 |
0.471 |
|
| 2010 |
Kunigal SS, Batra SK, Chellappan SP. Abstract 2948: Nicotine-induced expression of MUC4 in pancreatic cancer cells is mediated by E2F1 and STAT-1 upregulation: Relevance to smoking and pancreatic cancer Cancer Research. 70: 2948-2948. DOI: 10.1158/1538-7445.Am10-2948 |
0.464 |
|
| 2010 |
Baine M, Chakraborty S, Smith L, Mallya K, Sasson A, Batra S. Abstract 1980: Transcriptional profiling in peripheral blood mononuclear cells of patients with pancreatic cancer identifies several genes with potential diagnostic and prognostic implications Cancer Research. 70: 1980-1980. DOI: 10.1158/1538-7445.Am10-1980 |
0.457 |
|
| 2010 |
Ponnusamy MP, Lakshmanan I, Jain M, Das S, Chakraborty S, Dey P, Batra SK. Erratum: MUC4 mucin-induced epithelial to mesenchymal transition: A novel mechanism for metastasis of human ovarian cancer cells (Oncogene (2010) 29 (5741-5754) DOI: 10.1038/onc.2010.309) Oncogene. 29. DOI: 10.1038/Onc.2010.472 |
0.599 |
|
| 2009 |
Rachagani S, Torres MP, Moniaux N, Batra SK. Current status of mucins in the diagnosis and therapy of cancer Biofactors. 35: 509-527. PMID 19904814 DOI: 10.1002/Biof.64 |
0.452 |
|
| 2009 |
Ponnusamy MP, Deb S, Dey P, Chakraborty S, Rachagani S, Senapati S, Batra SK. RNA polymerase II associated factor 1/PD2 maintains self-renewal by its interaction with Oct3/4 in mouse embryonic stem cells. Stem Cells (Dayton, Ohio). 27: 3001-11. PMID 19821493 DOI: 10.1002/Stem.237 |
0.623 |
|
| 2009 |
Moniaux N, Nemos C, Deb S, Zhu B, Dornreiter I, Hollingsworth MA, Batra SK. The human RNA polymerase II-associated factor 1 (hPaf1): a new regulator of cell-cycle progression. Plos One. 4: e7077. PMID 19771162 DOI: 10.1371/Journal.Pone.0007077 |
0.558 |
|
| 2009 |
Bafna S, Kaur S, Momi N, Batra SK. Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin. British Journal of Cancer. 101: 1155-61. PMID 19738614 DOI: 10.1038/Sj.Bjc.6605285 |
0.821 |
|
| 2009 |
Mimeault M, Batra SK. Characterization of nonmalignant and malignant prostatic stem/progenitor cells by Hoechst side population method Methods in Molecular Biology (Clifton, N.J.). 568: 139-149. PMID 19582424 DOI: 10.1007/978-1-59745-280-9_8 |
0.421 |
|
| 2009 |
Zhang L, Davis JS, Zelivianski S, Lin FF, Schutte R, Davis TL, Hauke R, Batra SK, Lin MF. Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by gemcitabine in an androgen-reduced environment. Cancer Letters. 285: 58-65. PMID 19467571 DOI: 10.1016/J.Canlet.2009.04.041 |
0.388 |
|
| 2009 |
Munro EG, Jain M, Oliva E, Kamal N, Lele SM, Lynch MP, Guo L, Fu K, Sharma P, Remmenga S, Growdon WB, Davis JS, Rueda BR, Batra SK. Upregulation of MUC4 in cervical squamous cell carcinoma: pathologic significance. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 28: 127-33. PMID 19188823 DOI: 10.1097/Pgp.0B013E318184F3E0 |
0.335 |
|
| 2009 |
Mimeault M, Batra SK. Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications Ageing Research Reviews. 8: 94-112. PMID 19114129 DOI: 10.1016/J.Arr.2008.12.001 |
0.384 |
|
| 2009 |
Kunte D, Weber CR, Batra SK, Das S, Senapati S, Wali RK, Koetsier J, Roy HK. W1878 Muc4: A Novel Tumor Suppressor Gene Impacts Upon Initiation and Progression Phases of Colorectal Carcinogenesis Gastroenterology. 136: A-745. DOI: 10.1016/S0016-5085(09)63437-5 |
0.302 |
|
| 2009 |
Resta SC, Luu YH, Junker WM, Rachagani S, Moore ED, Batra SK, Ho SB. M1697 The Membrane Bound MUC17 Mucin Protects Cell Integrity in Response to Short Term Infection with Enteroinvasive E. coli Gastroenterology. 136: A-412-A-413. DOI: 10.1016/S0016-5085(09)61897-7 |
0.736 |
|
| 2009 |
Mimeault M, Batra SK. Potential molecular therapeutic targets in cancer stem/progenitor cells: Are ATP-binding cassette membrane transporters appropriate targets to eliminate cancer-initiating cells? Stem Cell Biology in Health and Disease. 385-421. DOI: 10.1007/978-90-481-3040-5_17 |
0.346 |
|
| 2008 |
Deb S, Ponnusamy MP, Senapati S, Dey P, Batra SK. Human PAF complexes in endocrine tumors and pancreatic cancer. Expert Review of Endocrinology & Metabolism. 3: 557-565. PMID 30290411 DOI: 10.1586/17446651.3.5.557 |
0.68 |
|
| 2008 |
Chakraborty S, Jain M, Sasson AR, Batra SK. MUC4 as a diagnostic marker in cancer. Expert Opinion On Medical Diagnostics. 2: 891-910. PMID 23495864 DOI: 10.1517/17530059.2.8.891 |
0.396 |
|
| 2008 |
Ponnusamy MP, Batra SK. Ovarian cancer: emerging concept on cancer stem cells. Journal of Ovarian Research. 1: 4. PMID 19014671 DOI: 10.1186/1757-2215-1-4 |
0.43 |
|
| 2008 |
Singh AP, Senapati S, Ponnusamy MP, Jain M, Lele SM, Davis JS, Remmenga S, Batra SK. Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer. The Lancet. Oncology. 9: 1076-85. PMID 19012856 DOI: 10.1016/S1470-2045(08)70277-8 |
0.428 |
|
| 2008 |
Bafna S, Singh AP, Moniaux N, Eudy JD, Meza JL, Batra SK. MUC4, a multifunctional transmembrane glycoprotein, induces oncogenic transformation of NIH3T3 mouse fibroblast cells. Cancer Research. 68: 9231-8. PMID 19010895 DOI: 10.1158/0008-5472.Can-08-3135 |
0.709 |
|
| 2008 |
Senapati S, Sharma P, Bafna S, Roy HK, Batra SK. The MUC gene family: their role in the diagnosis and prognosis of gastric cancer. Histology and Histopathology. 23: 1541-52. PMID 18830939 DOI: 10.14670/Hh-23.1541 |
0.644 |
|
| 2008 |
Senapati S, Chaturvedi P, Sharma P, Venkatraman G, Meza JL, El-Rifai W, Roy HK, Batra SK. Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer. British Journal of Cancer. 99: 949-56. PMID 18781152 DOI: 10.1038/Sj.Bjc.6604632 |
0.594 |
|
| 2008 |
Ponnusamy MP, Singh AP, Jain M, Chakraborty S, Moniaux N, Batra SK. MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells. British Journal of Cancer. 99: 520-6. PMID 18665193 DOI: 10.1038/Sj.Bjc.6604517 |
0.477 |
|
| 2008 |
Matull WR, Andreola F, Loh A, Adiguzel Z, Deheragoda M, Qureshi U, Batra SK, Swallow DM, Pereira SP. MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. British Journal of Cancer. 98: 1675-81. PMID 18475301 DOI: 10.1038/Sj.Bjc.6604364 |
0.403 |
|
| 2008 |
Mimeault M, Batra SK. Targeting of cancer stem/progenitor cells plus stem cell-based therapies: The ultimate hope for treating and curing aggressive and recurrent cancers Panminerva Medica. 50: 3-18. PMID 18427384 |
0.339 |
|
| 2008 |
Moniaux N, Chakraborty S, Yalniz M, Gonzalez J, Shostrom VK, Standop J, Lele SM, Ouellette M, Pour PM, Sasson AR, Brand RE, Hollingsworth MA, Jain M, Batra SK. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. British Journal of Cancer. 98: 1540-7. PMID 18392050 DOI: 10.1038/Sj.Bjc.6604329 |
0.478 |
|
| 2008 |
Chaturvedi P, Singh AP, Chakraborty S, Chauhan SC, Bafna S, Meza JL, Singh PK, Hollingsworth MA, Mehta PP, Batra SK. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. Cancer Research. 68: 2065-70. PMID 18381409 DOI: 10.1158/0008-5472.Can-07-6041 |
0.773 |
|
| 2008 |
Wittel UA, Wiech T, Chakraborty S, Boss B, Lauch R, Batra SK, Hopt UT. Taurocholate-induced pancreatitis: A model of severe necrotizing pancreatitis in mice Pancreas. 36. PMID 18376298 DOI: 10.1097/Mpa.0B013E3181575103 |
0.322 |
|
| 2008 |
Mimeault M, Mehta PP, Hauke R, Batra SK. Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies. Endocrine Reviews. 29: 234-52. PMID 18292464 DOI: 10.1210/Er.2007-0040 |
0.39 |
|
| 2008 |
Mimeault M, Batra SK. Recent progress on tissue-resident adult stem cell biology and their therapeutic implications Stem Cell Reviews. 4: 27-49. PMID 18288619 DOI: 10.1007/S12015-008-9008-2 |
0.374 |
|
| 2008 |
Chaturvedi P, Singh AP, Batra SK. Structure, evolution, and biology of the MUC4 mucin. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 966-81. PMID 18024835 DOI: 10.1096/Fj.07-9673Rev |
0.6 |
|
| 2008 |
Singh AP, Bafna S, Chaudhary K, Venkatraman G, Smith L, Eudy JD, Johansson SL, Lin MF, Batra SK. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells. Cancer Letters. 259: 28-38. PMID 17977648 DOI: 10.1016/J.Canlet.2007.09.018 |
0.678 |
|
| 2008 |
Mimeault M, Hauke R, Batra SK. Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies Clinical Pharmacology and Therapeutics. 83: 673-691. PMID 17786164 DOI: 10.1038/Sj.Clpt.6100296 |
0.439 |
|
| 2008 |
Chakraborty S, Jain M, Sasson AR, Batra SK. MUC4 as a diagnostic marker in cancer Expert Opinion On Medical Diagnostics. 2: 891-910. DOI: 10.1517/17530059.2.8.891 |
0.372 |
|
| 2008 |
Chaturvedi P, Singh AP, Chakraborty S, Chauhan SC, Bafna S, Meza JL, Singh PK, Hollingsworth MA, Mehta PP, Batra SK. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells (Cancer Research (April 1, 2008) 68(2065-2070)) Cancer Research. 68: 3549. DOI: 10.1158/0008-5472.Can-68-9-Cor3 |
0.746 |
|
| 2008 |
Mimeault M, Batra SK. Recent advances in the development of novel anti-cancer drugs targeting cancer stem/progenitor cells Drug Development Research. 69: 415-430. DOI: 10.1002/Ddr.20273 |
0.468 |
|
| 2007 |
Mimeault M, Mehta PP, Hauke R, Henichart JP, Depreux P, Lin MF, Batra SK. Improvement of cytotoxic effects induced by mitoxantrone on hormone-refractory metastatic prostate cancer cells by co-targeting epidermal growth factor receptor and hedgehog signaling cascades. Growth Factors (Chur, Switzerland). 25: 400-16. PMID 18365871 DOI: 10.1080/08977190801930935 |
0.381 |
|
| 2007 |
Mimeault M, Hauke R, Mehta PP, Batra SK. Recent advances in cancer stem/progenitor cell research: Therapeutic implications for overcoming resistance to the most aggressive cancers: Stem Cells Review Series Journal of Cellular and Molecular Medicine. 11: 981-1011. PMID 17979879 DOI: 10.1111/J.1582-4934.2007.00088.X |
0.468 |
|
| 2007 |
Mimeault M, Hauke R, Batra SK. Stem cells: A revolution in therapeutics - Recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies Clinical Pharmacology and Therapeutics. 82: 252-264. PMID 17671448 DOI: 10.1038/Sj.Clpt.6100301 |
0.363 |
|
| 2007 |
Chaudhary K, Deb S, Moniaux N, Ponnusamy MP, Batra SK. Human RNA polymerase II-associated factor complex: dysregulation in cancer. Oncogene. 26: 7499-507. PMID 17599057 DOI: 10.1038/Sj.Onc.1210582 |
0.526 |
|
| 2007 |
Moniaux N, Chaturvedi P, Varshney GC, Meza JL, Rodriguez-Sierra JF, Aubert JP, Batra SK. Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells. British Journal of Cancer. 97: 345-57. PMID 17595659 DOI: 10.1038/Sj.Bjc.6603868 |
0.683 |
|
| 2007 |
Andrianifahanana M, Singh AP, Nemos C, Ponnusamy MP, Moniaux N, Mehta PP, Varshney GC, Batra SK. IFN-gamma-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation: a novel mechanism for IFN-gamma response. Oncogene. 26: 7251-61. PMID 17525742 DOI: 10.1038/Sj.Onc.1210532 |
0.742 |
|
| 2007 |
Jain M, Venkatraman G, Batra SK. Cell-penetrating peptides and antibodies: A new direction for optimizing radioimmunotherapy European Journal of Nuclear Medicine and Molecular Imaging. 34: 973-977. PMID 17453198 DOI: 10.1007/S00259-007-0395-4 |
0.323 |
|
| 2007 |
Chaturvedi P, Singh AP, Moniaux N, Senapati S, Chakraborty S, Meza JL, Batra SK. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Molecular Cancer Research : McR. 5: 309-20. PMID 17406026 DOI: 10.1158/1541-7786.Mcr-06-0353 |
0.682 |
|
| 2007 |
Mimeault M, Johansson SL, Vankatraman G, Moore E, Henichart JP, Depreux P, Lin MF, Batra SK. Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells. Molecular Cancer Therapeutics. 6: 967-78. PMID 17363490 DOI: 10.1158/1535-7163.Mct-06-0648 |
0.386 |
|
| 2007 |
Mimeault M, Batra SK. Interplay of distinct growth factors during epithelial-mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies Annals of Oncology. 18: 1605-1619. PMID 17355951 DOI: 10.1093/Annonc/Mdm070 |
0.454 |
|
| 2007 |
Jain M, Venkatraman G, Batra SK. Optimization of radioimmunotherapy of solid tumors: Biological impediments and their modulation Clinical Cancer Research. 13: 1374-1382. PMID 17309914 DOI: 10.1158/1078-0432.Ccr-06-2436 |
0.331 |
|
| 2007 |
Mimeault M, Batra SK. Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications Cancer and Metastasis Reviews. 26: 203-214. PMID 17273942 DOI: 10.1007/S10555-007-9052-4 |
0.47 |
|
| 2007 |
Singh AP, Chaturvedi P, Batra SK. Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy. Cancer Research. 67: 433-6. PMID 17234748 DOI: 10.1158/0008-5472.Can-06-3114 |
0.635 |
|
| 2007 |
Chen SJ, Karan D, Johansson SL, Lin FF, Zeckser J, Singh AP, Batra SK, Lin MF. Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells. The Prostate. 67: 557-71. PMID 17221842 DOI: 10.1002/Pros.20551 |
0.324 |
|
| 2007 |
Ponnusamy MP, Venkatraman G, Singh AP, Chauhan SC, Johansson SL, Jain M, Smith L, Davis JS, Remmenga SW, Batra SK. Expression of TAG-72 in ovarian cancer and its correlation with tumor stage and patient prognosis. Cancer Letters. 251: 247-57. PMID 17210225 DOI: 10.1016/J.Canlet.2006.11.025 |
0.443 |
|
| 2007 |
Mimeault M, Venkatraman G, Johansson SL, Moore E, Henichart JP, Depreux P, Lin MF, Batra SK. Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide. International Journal of Cancer. Journal International Du Cancer. 120: 160-9. PMID 17013895 DOI: 10.1002/Ijc.22268 |
0.355 |
|
| 2007 |
Singh AP, Chauhan SC, Andrianifahanana M, Moniaux N, Meza JL, Copin MC, van Seuningen I, Hollingsworth MA, Aubert JP, Batra SK. MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms. Oncogene. 26: 30-41. PMID 16799633 DOI: 10.1038/Sj.Onc.1209764 |
0.762 |
|
| 2006 |
Tsutsumida H, Goto M, Kitajima S, Kubota I, Hirotsu Y, Wakimoto J, Batra SK, Imai K, Yonezawa S. MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma. Lung Cancer (Amsterdam, Netherlands). 55: 195-203. PMID 17126950 DOI: 10.1016/J.Lungcan.2006.10.013 |
0.338 |
|
| 2006 |
Wittel UA, Singh AP, Henley BJ, Andrianifahanana M, Akhter MP, Cullen DM, Batra SK. Cigarette smoke-induced differential expression of the genes involved in exocrine function of the rat pancreas. Pancreas. 33: 364-70. PMID 17079941 DOI: 10.1097/01.Mpa.0000240601.80570.31 |
0.735 |
|
| 2006 |
Mitra S, Annamalai L, Chakraborty S, Johnson K, Song XH, Batra SK, Mehta PP. Androgen-regulated formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. Molecular Biology of the Cell. 17: 5400-16. PMID 17050739 DOI: 10.1091/Mbc.E06-04-0280 |
0.345 |
|
| 2006 |
Andrianifahanana M, Chauhan SC, Choudhury A, Moniaux N, Brand RE, Sasson AA, Pour PM, Batra SK. MUC4-expressing pancreatic adenocarcinomas show elevated levels of both T1 and T2 cytokines: potential pathobiologic implications. The American Journal of Gastroenterology. 101: 2319-29. PMID 17032197 DOI: 10.1111/J.1572-0241.2006.00871.X |
0.765 |
|
| 2006 |
Jhala N, Jhala D, Vickers SM, Eltoum I, Batra SK, Manne U, Eloubeidi M, Jones JJ, Grizzle WE. Biomarkers in Diagnosis of pancreatic carcinoma in fine-needle aspirates. American Journal of Clinical Pathology. 126: 572-9. PMID 17019794 DOI: 10.1309/Cev30Be088Cbdqd9 |
0.36 |
|
| 2006 |
Ringel J, Jesnowski R, Moniaux N, Lüttges J, Ringel J, Choudhury A, Batra SK, Klöppel G, Löhr M. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma. Cancer Research. 66: 9045-53. PMID 16982746 DOI: 10.1158/0008-5472.Can-05-3287 |
0.432 |
|
| 2006 |
Chauhan SC, Singh AP, Ruiz F, Johansson SL, Jain M, Smith LM, Moniaux N, Batra SK. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 19: 1386-94. PMID 16880776 DOI: 10.1038/Modpathol.3800646 |
0.365 |
|
| 2006 |
Tamada S, Shibahara H, Higashi M, Goto M, Batra SK, Imai K, Yonezawa S. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 4257-64. PMID 16857800 DOI: 10.1158/1078-0432.Ccr-05-2814 |
0.334 |
|
| 2006 |
Mimeault M, Batra SK. Concise review: Recent advances on the significance of stem cells in tissue regeneration and cancer therapies Stem Cells. 24: 2319-2345. PMID 16794264 DOI: 10.1634/Stemcells.2006-0066 |
0.4 |
|
| 2006 |
Moniaux N, Junker WM, Singh AP, Jones AM, Batra SK. Characterization of human mucin MUC17. Complete coding sequence and organization. The Journal of Biological Chemistry. 281: 23676-85. PMID 16737958 DOI: 10.1074/Jbc.M600302200 |
0.77 |
|
| 2006 |
Yuan TC, Veeramani S, Lin FF, Kondrikou D, Zelivianski S, Igawa T, Karan D, Batra SK, Lin MF. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells. Endocrine-Related Cancer. 13: 151-67. PMID 16601285 DOI: 10.1677/Erc.1.01043 |
0.402 |
|
| 2006 |
Moniaux N, Nemos C, Schmied BM, Chauhan SC, Deb S, Morikane K, Choudhury A, Vanlith M, Sutherlin M, Sikela JM, Hollingsworth MA, Batra SK. The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis. Oncogene. 25: 3247-57. PMID 16491129 DOI: 10.1038/Sj.Onc.1209353 |
0.523 |
|
| 2006 |
Andrianifahanana M, Moniaux N, Batra SK. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochimica Et Biophysica Acta. 1765: 189-222. PMID 16487661 DOI: 10.1016/J.Bbcan.2006.01.002 |
0.764 |
|
| 2006 |
Wittel UA, Pandey KK, Andrianifahanana M, Johansson SL, Cullen DM, Akhter MP, Brand RE, Prokopczyk B, Batra SK. Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. The American Journal of Gastroenterology. 101: 148-59. PMID 16405548 DOI: 10.1111/J.1572-0241.2006.00405.X |
0.722 |
|
| 2006 |
Singh AP, Chauhan SC, Bafna S, Johansson SL, Smith LM, Moniaux N, Lin MF, Batra SK. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas. The Prostate. 66: 421-9. PMID 16302265 DOI: 10.1002/Pros.20372 |
0.689 |
|
| 2006 |
Mimeault M, Batra SK. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies Carcinogenesis. 27: 1-22. PMID 16195239 DOI: 10.1093/Carcin/Bgi229 |
0.375 |
|
| 2006 |
Mimeault M, Moore E, Moniaux N, Hénichart JP, Depreux P, Lin MF, Batra SK. Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells. International Journal of Cancer. Journal International Du Cancer. 118: 1022-31. PMID 16108016 DOI: 10.1002/Ijc.21440 |
0.371 |
|
| 2005 |
Mimeault M, Brand RE, Sasson AA, Batra SK. Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies Pancreas. 31: 301-316. PMID 16258363 DOI: 10.1097/01.Mpa.0000175893.04660.1B |
0.446 |
|
| 2005 |
Saitou M, Goto M, Horinouchi M, Tamada S, Nagata K, Hamada T, Osako M, Takao S, Batra SK, Aikou T, Imai K, Yonezawa S. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. Journal of Clinical Pathology. 58: 845-52. PMID 16049287 DOI: 10.1136/Jcp.2004.023572 |
0.314 |
|
| 2005 |
Andrianifahanana M, Agrawal A, Singh AP, Moniaux N, van Seuningen I, Aubert JP, Meza J, Batra SK. Synergistic induction of the MUC4 mucin gene by interferon-gamma and retinoic acid in human pancreatic tumour cells involves a reprogramming of signalling pathways. Oncogene. 24: 6143-54. PMID 16007204 DOI: 10.1038/Sj.Onc.1208756 |
0.73 |
|
| 2005 |
Standop J, Andrianifahanana M, Moniaux N, Schneider M, Ulrich A, Brand RE, Wisecarver JL, Bridge JA, Büchler MW, Adrian TE, Batra SK, Pour PM. ErbB2 growth factor receptor, a marker for neuroendocrine cells? Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.]. 5: 44-58. PMID 15775699 DOI: 10.1159/000084490 |
0.792 |
|
| 2005 |
Clark JW, Zhu AX, Rattner DW, Winkelmann JL, Warshaw AL, Vaysse N, Lamprecht G, Mau UA, Kortüm C, Raible A, Stern M, Rieβ O, Gregor M, Ryan DP, Lomberk G, ... ... Batra SK, et al. LAPSG Society News Pancreatology. 5: 112. DOI: 10.1159/000084900 |
0.672 |
|
| 2005 |
Clark JW, Zhu AX, Rattner DW, Winkelmann JL, Warshaw AL, Vaysse N, Lamprecht G, Mau UA, Kortüm C, Raible A, Stern M, Rieβ O, Gregor M, Ryan DP, Lomberk G, ... ... Batra SK, et al. 30th Annual Meeting of the Pancreatic Society of Great Britain and Irelandy Pancreatology. 5: 97-107. DOI: 10.1159/000084401 |
0.705 |
|
| 2004 |
Moniaux N, Andrianifahanana M, Brand RE, Batra SK. Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy. British Journal of Cancer. 91: 1633-8. PMID 15494719 DOI: 10.1038/Sj.Bjc.6602163 |
0.769 |
|
| 2004 |
Jonckheere N, Perrais M, Mariette C, Batra SK, Aubert JP, Pigny P, Van Seuningen I. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis. Oncogene. 23: 5729-38. PMID 15184872 DOI: 10.1038/Sj.Onc.1207769 |
0.359 |
|
| 2004 |
Shibahara H, Tamada S, Goto M, Oda K, Nagino M, Nagasaka T, Batra SK, Hollingsworth MA, Imai K, Nimura Y, Yonezawa S. Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. The American Journal of Surgical Pathology. 28: 327-38. PMID 15104295 DOI: 10.1097/00000478-200403000-00005 |
0.339 |
|
| 2004 |
Saruc M, Standop S, Standop J, Nozawa F, Itami A, Pandey KK, Batra SK, Gonzalez NJ, Guesry P, Pour PM. Pancreatic enzyme extract improves survival in murine pancreatic cancer. Pancreas. 28: 401-12. PMID 15097858 DOI: 10.1097/00006676-200405000-00009 |
0.396 |
|
| 2004 |
Choudhury A, Moniaux N, Ulrich AB, Schmied BM, Standop J, Pour PM, Gendler SJ, Hollingsworth MA, Aubert JP, Batra SK. MUC4 mucin expression in human pancreatic tumours is affected by organ environment: the possible role of TGFbeta2. British Journal of Cancer. 90: 657-64. PMID 14760381 DOI: 10.1038/Sj.Bjc.6601604 |
0.412 |
|
| 2004 |
Shibahara H, Tamada S, Higashi M, Goto M, Batra SK, Hollingsworth MA, Imai K, Yonezawa S. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology (Baltimore, Md.). 39: 220-9. PMID 14752841 DOI: 10.1002/Hep.20031 |
0.36 |
|
| 2004 |
Singh AP, Moniaux N, Chauhan SC, Meza JL, Batra SK. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Research. 64: 622-30. PMID 14744777 DOI: 10.1158/0008-5472.Can-03-2636 |
0.456 |
|
| 2004 |
Moniaux N, Varshney GC, Chauhan SC, Copin MC, Jain M, Wittel UA, Andrianifahanana M, Aubert JP, Batra SK. Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 52: 253-61. PMID 14729877 DOI: 10.1177/002215540405200213 |
0.742 |
|
| 2004 |
Llinares K, Escande F, Aubert S, Buisine MP, de Bolos C, Batra SK, Gosselin B, Aubert JP, Porchet N, Copin MC. Diagnostic value of MUC4 immunostaining in distinguishing epithelial mesothelioma and lung adenocarcinoma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 17: 150-7. PMID 14657954 DOI: 10.1038/Modpathol.3800027 |
0.345 |
|
| 2004 |
Mariette C, Perrais M, Leteurtre E, Jonckheere N, Hémon B, Pigny P, Batra S, Aubert JP, Triboulet JP, Van Seuningen I. Transcriptional regulation of human mucin MUC4 by bile acids in oesophageal cancer cells is promoter-dependent and involves activation of the phosphatidylinositol 3-kinase signalling pathway. The Biochemical Journal. 377: 701-8. PMID 14583090 DOI: 10.1042/Bj20031132 |
0.348 |
|
| 2004 |
Ringel J, Lüttges J, Jesenowski R, Batra S, Löhr M. ABERRANT ADAM17/TACE EXPRESSION AS POTENTIAL “LATE EVENT” IN THE DEVELOPMENT OF HUMAN DUCTAL PANCREATIC ADENOCARCINOMA. Pancreas. 29: 354. DOI: 10.1097/00006676-200411000-00110 |
0.368 |
|
| 2003 |
Karan D, Chen SJ, Johansson SL, Singh AP, Paralkar VM, Lin MF, Batra SK. Dysregulated expression of MIC-1/PDF in human prostate tumor cells. Biochemical and Biophysical Research Communications. 305: 598-604. PMID 12763036 DOI: 10.1016/S0006-291X(03)00823-4 |
0.355 |
|
| 2003 |
Pour PM, Bell RH, Batra SK. Neural invasion in the staging of pancreatic cancer Pancreas. 26: 322-325. PMID 12717262 DOI: 10.1097/00006676-200305000-00002 |
0.373 |
|
| 2003 |
Park HU, Kim JW, Kim GE, Bae HI, Crawley SC, Yang SC, Gum JR, Batra SK, Rousseau K, Swallow DM, Sleisenger MH, Kim YS. Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia. Pancreas. 26: e48-54. PMID 12657964 DOI: 10.1097/00006676-200304000-00022 |
0.416 |
|
| 2003 |
Pour PM, Pandey KK, Batra SK. What is the origin of pancreatic adenocarcinoma? Molecular Cancer. 2. PMID 12636873 DOI: 10.1186/1476-4598-2-13 |
0.434 |
|
| 2003 |
Karan D, Lin MF, Johansson SL, Batra SK. Current status of the molecular genetics of human prostatic adenocarcinomas. International Journal of Cancer. 103: 285-93. PMID 12471610 DOI: 10.1002/Ijc.10813 |
0.357 |
|
| 2003 |
Karan D, Lin FC, Bryan M, Ringel J, Moniaux N, Lin M, Batra SK. Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas. International Journal of Oncology. 23: 1365-1371. DOI: 10.3892/Ijo.23.5.1365 |
0.385 |
|
| 2002 |
Standop J, Schneider MB, Ulrich A, Chauhan S, Moniaux N, Büchler MW, Batra SK, Pour PM. The pattern of xenobiotic-metabolizing enzymes in the human pancreas. Journal of Toxicology and Environmental Health. Part A. 65: 1379-400. PMID 12396872 DOI: 10.1080/00984100290071603 |
0.343 |
|
| 2002 |
Pour PM, Standop J, Batra SK. Are islet cells the gatekeepers of the pancreas? Pancreatology. 2: 440-448. PMID 12378111 DOI: 10.1159/000064718 |
0.378 |
|
| 2002 |
Swartz MJ, Batra SK, Varshney GC, Hollingsworth MA, Yeo CJ, Cameron JL, Wilentz RE, Hruban RH, Argani P. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. American Journal of Clinical Pathology. 117: 791-6. PMID 12090430 DOI: 10.1309/7Y7N-M1Wm-R0Yk-M2Va |
0.351 |
|
| 2002 |
Karan D, Kelly DL, Rizzino A, Lin MF, Batra SK. Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells. Carcinogenesis. 23: 967-75. PMID 12082018 DOI: 10.1093/Carcin/23.6.967 |
0.379 |
|
| 2002 |
Igawa T, Lin FF, Lee MS, Karan D, Batra SK, Lin MF. Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model. The Prostate. 50: 222-35. PMID 11870800 DOI: 10.1002/Pros.10054 |
0.351 |
|
| 2002 |
Khorrami AM, Choudhury A, Andrianifahanana M, Varshney GC, Bhattacharyya SN, Hollingsworth MA, Kaufman B, Batra SK. Purification and characterization of a human pancreatic adenocarcinoma mucin. Journal of Biochemistry. 131: 21-9. PMID 11754731 DOI: 10.1093/Oxfordjournals.Jbchem.A003073 |
0.726 |
|
| 2002 |
Schmied BM, Ulrich A, Matsuzaki H, Ding X, Ricordi C, Weide L, Moyer MP, Batra SK, Adrian TE, Pour PM. Transdifferentiation of human islet cells in a long-term culture. Pancreas. 23: 157-71. PMID 11484918 DOI: 10.1097/00006676-200108000-00006 |
0.35 |
|
| 2001 |
Andrianifahanana M, Moniaux N, Schmied BM, Ringel J, Friess H, Hollingsworth MA, Büchler MW, Aubert JP, Batra SK. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 4033-40. PMID 11751498 |
0.748 |
|
| 2001 |
Muscarella P, Knobloch TJ, Ulrich AB, Casto BC, Moniaux N, Wittel UA, Melvin WS, Pour PM, Song H, Gold B, Batra SK, Weghorst CM. Identification and sequencing of the Syrian Golden hamster (Mesocricetus auratus) p16INK4a and p15INK4b cDNAs and their homozygous gene deletion in cheek pouch and pancreatic tumor cells Gene. 278: 235-243. PMID 11707341 DOI: 10.1016/S0378-1119(01)00728-4 |
0.415 |
|
| 2001 |
Wittel UA, Goel A, Varshney GC, Batra SK. Mucin antibodies - new tools in diagnosis and therapy of cancer Frontiers in Bioscience : a Journal and Virtual Library. 6. PMID 11578978 DOI: 10.2741/Wittel |
0.451 |
|
| 2001 |
Moniaux N, Escande F, Porchet N, Aubert JP, Batra SK. Structural organization and classification of the human mucin genes. Frontiers in Bioscience : a Journal and Virtual Library. 6: D1192-206. PMID 11578969 DOI: 10.2741/Moniaux |
0.324 |
|
| 2001 |
Karan D, Johansson SL, Lin MF, Batra SK. Expression of tumor-associated glycoprotein-72 (TAG-72) antigen in human prostatic adenocarcinomas. Oncology Reports. 8: 1123-6. PMID 11496328 DOI: 10.3892/Or.8.5.1123 |
0.385 |
|
| 2001 |
Silverman HS, Parry S, Sutton-Smith M, Burdick MD, McDermott K, Reid CJ, Batra SK, Morris HR, Hollingsworth MA, Dell A, Harris A. In vivo glycosylation of mucin tandem repeats. Glycobiology. 11: 459-71. PMID 11445551 DOI: 10.1093/Glycob/11.6.459 |
0.301 |
|
| 2001 |
Ringel J, Jesnowski R, Schmidt C, Ringel J, Köhler HJ, Rychly J, Batra SK, Löhr M. CD44 in normal human pancreas and pancreatic carcinoma cell lines. Teratogenesis, Carcinogenesis, and Mutagenesis. 21: 97-106. PMID 11135324 DOI: 10.1002/1520-6866(2001)21:1<97::Aid-Tcm9>3.0.Co;2-O |
0.406 |
|
| 2001 |
Choudhury A, Moniaux N, Ringel J, King J, Moore E, Aubert JP, Batra SK. Alternate splicing at the 3'-end of the human pancreatic tumor-associated mucin MUC4 cDNA. Teratogenesis, Carcinogenesis, and Mutagenesis. 21: 83-96. PMID 11135323 DOI: 10.1002/1520-6866(2001)21:1<83::Aid-Tcm8>3.0.Co;2-3 |
0.385 |
|
| 2001 |
Goel A, Batra SK. Antibody constructs for radioimmunodiagnosis and treatment of human pancreatic cancer. Teratogenesis, Carcinogenesis, and Mutagenesis. 21: 45-57. PMID 11135320 DOI: 10.1002/1520-6866(2001)21:1<45::Aid-Tcm5>3.0.Co;2-A |
0.392 |
|
| 2001 |
Ulrich AB, Schmied BM, Matsuzaki H, El-Metwally T, Moyer MP, Ricordi C, Adrian TE, Batra SK, Pour PM. Establishment of human pancreatic ductal cells in a long-term culture. Pancreas. 21: 358-68. PMID 11075990 DOI: 10.1097/00006676-200011000-00006 |
0.339 |
|
| 2001 |
Brand RE, Ringel J, Faulmann G, Moniaux N, Lohr M, Batra SK. The combination of CA 19-9 and MUC4 mRNA in peripheral blood mononuclear cells improves the sensitivity of either marker alone for the diagnosis of pancreatic adenocarcinoma Gastroenterology. 120: A609. DOI: 10.1016/S0016-5085(08)83029-6 |
0.319 |
|
| 2000 |
Choudhury A, Singh RK, Moniaux N, El-Metwally TH, Aubert JP, Batra SK. Retinoic acid-dependent transforming growth factor-beta 2-mediated induction of MUC4 mucin expression in human pancreatic tumor cells follows retinoic acid receptor-alpha signaling pathway. The Journal of Biological Chemistry. 275: 33929-36. PMID 10938282 DOI: 10.1074/Jbc.M005115200 |
0.333 |
|
| 2000 |
Choudhury A, Moniaux N, Winpenny JP, Hollingsworth MA, Aubert JP, Batra SK. Human MUC4 mucin cDNA and its variants in pancreatic carcinoma Journal of Biochemistry. 128: 233-243. PMID 10920259 DOI: 10.1093/Oxfordjournals.Jbchem.A022746 |
0.362 |
|
| 2000 |
Schmied BM, Liu G, Matsuzaki H, Ulrich A, Hernberg S, Moyer MP, Weide L, Murphy L, Batra SK, Pour PM. Differentiation of islet cells in long-term culture. Pancreas. 20: 337-47. PMID 10824687 DOI: 10.1097/00006676-200005000-00002 |
0.39 |
|
| 2000 |
Goel A, Beresford GW, Colcher D, Pavlinkova G, Booth BJ, Baranowska-Kortylewicz J, Batra SK. Divalent forms of CC49 single-chain antibody constructs in Pichia pastoris: expression, purification, and characterization. Journal of Biochemistry. 127: 829-36. PMID 10788792 DOI: 10.1093/Oxfordjournals.Jbchem.A022676 |
0.332 |
|
| Show low-probability matches. |